Donovanosis (Granuloma Inguinale) Virendra N Sehgal, Arakali L Shyam Prasad
INDEX
×
Chapter Notes

Save Clear


Jaypee Brothers Medical Publishers (P) Ltd
Headquarter
Jaypee Brothers Medical Publishers (P) Ltd
4838/24, Ansari Road, Daryaganj
New Delhi 110 002, India
Phone: +91-11-43574357
Fax: +91-11-43574314
Overseas Offices
J.P. Medical Ltd
83 Victoria Street, London
SW1H 0HW (UK)
Phone: +44-2031708910
Fax: +02-03-0086180
Jaypee-Highlights Medical Publishers Inc
City of Knowledge, Bld. 237, Clayton
Panama City, Panama
Phone: + 507-301-0496
Fax: + 507-301-0499
Jaypee Brothers Medical Publishers (P) Ltd
17/1-B Babar Road, Block-B, Shaymali
Mohammadpur, Dhaka-1207
Bangladesh
Mobile: +08801912003485
Jaypee Brothers Medical Publishers (P) Ltd
Shorakhute, Kathmandu
Nepal
Phone: +00977-9841528578
Jaypee Brothers Medical Publishers Ltd
The Bourse
111 South Independence Mall East
Suite 835, Philadelphia, PA 19106, USA
Phone: + 267-519-9789
© 2013, Jaypee Brothers Medical Publishers
All rights reserved. No part of this book may be reproduced in any form or by any means without the prior permission of the publisher.
Inquiries for bulk sales may be solicited at: jaypee@jaypeebrothers.com
This book has been published in good faith that the contents provided by the author contained herein are original, and is intended for educational purposes only. While every effort is made to ensure accuracy of information, the publisher and the author specifically disclaim any damage, liability, or loss incurred, directly or indirectly, from the use or application of any of the contents of this work. If not specifically stated, all figures and tables are courtesy of the author. Where appropriate, the readers should consult with a specialist or contact the manufacturer of the drug or device.
Obstetric Vasculopathies
First Edition: 2013
9789350905142
Printed at

Introductionchapter 1

Donovanosis, is a fascinating, one of the chronic genito ulcerative diseases (GUDs) affecting primarily the genitalia. Its clinical, bacteriological, and histopathological features are characteristic enough to pinpoint the diagnosis. Even then this disease is largely missed or overlooked because it is neither suspected nor entertained in the differential diagnosis of ulcerative lesions on the genitalia.1 Furthermore, the utilization of syndromic diagnosis and treatment of sexually transmitted infections (STIs) in various parts of the world, and previous use of antibiotics make it difficult to find Donovan bodies in the cytodiagnostic and hystopathological examination, requiring the utilization of technology that is neither routine nor often accessible to confirm the hypothesized diagnosis. Therefore, it is necessary to bring medical professionals up to date about this infectious disease.2 It appears to be a universal impression because very little information on the disease is available from different parts of the globe. Its exclusive reporting from tropics and subtropics too seems misleading and evasive. Should the diagnosis of the disease be considered in all earnest in the differential diagnosis of genital ulcerations, more and more cases of the disease may be identified and superfluous connotation can be highlighted. An endeavor has, therefore, been made in the present text to consolidate its current status along with those of the previous works in a solemn bid to focus attention on this relatively neglected disease. Accordingly, the text has been profusely illustrated with black and white and colored photographs. The significance of the condition has relevantly been magnified, because this is one of the major genito ulcerative diseases (GUDs) responsible for propagating and perpetuating Human immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS). It is hoped that the present treatise achieves its objective, and serves as “ready reckoner” for practicing venereologists, general practitioners 2and above all under- and postgraduate students across the globe.
 
Definition
Donovanosis, one of the pre-eminent genital ulcerative diseases, is chronic mildly contagious, sexually transmitted disease, characterized by exquisite granulomatous ulceration of the genitalia and neighboring sites, Calymmatobacterium granulomatis being its causative organism.3
 
Nomenclature
The initial precise clinical description of the disease was outlined by Mcleod,4 when he named it as serpiginous ulceration of the groin. Ever since, its initial descriptions, the disease has been recognized by names, pointing accurately to its morphological features. An accurate clinical description of the disease was given by Conyers and Daniels5 while working in British Guiana. They used the term “lupoid form” of the so-called ‘groin ulceration’. While Galloway6 used the term ‘ulcerating granuloma of the pudenda’ in a single case report from London. Maitland7 described the condition under the title of ‘chronic venereal sores’. The condition was named ‘granuloma inguinale tropicum’ by Crocker8 in his textbook. However, Brooke9 coined it as ‘granuloma venereum’, a term which is still in vogue in some places. Donovanosis/Granuloma Inguinale (GI) is the current nomenclature used in practice and research across the globe. The same is adopted for the present text for all intends and purposes.
 
References
  1. Mein JK, Anstey NM, Bowden FJ. Missing the diagnosis of donovanosis in Northern Australia. Med J Aust. 1999;170:48.
  1. Velho PE, Souza EM, Belda Junior W. Donovanosis. Braz J Infect Dis. 2008;12:521–525.
  1. Rajam RV, Rangiah PN. Donovanosis. World Health Organisation Monograph 1954;24.
  1. McLeod K. Precis of operations performed in the wards of the first surgeon, Medical College Hospital during the year 1881, lnd Med Gaz. 1882;17:113–123.
  1. Conyers JH, Daniels CW. The lupoid form of the so-called “groin ulceration” of this colony. Br Guin Med Ann. 1896;8:13–20.
  1. Galloway J. Ulcerating granuloma of the pudenda. Br J Dermatol. 1897;8:13–20.
  1. Maitland J. Chronic veneral sores. lnd Med Gaz. 1898;23:164–166.
  1. Crocker HR; Diseases of the skin. P Blackiston and Co.  Philadelphia. 1903.
  1. Brooke GE. Tropical medicine, hygiene and parasitology. Charles Griffin & Co. Ltd,  London, 1900.

Etiopathogenesischapter 2

The major breakthrough came in the wake of recognizing intracellular bodies from an oral lesion of the disease by Donovan.1 They were later incriminated by the subsequent workers as the causative organisms of the disease. These are now called Donovan bodies as a gesture to their discoverer. Aragao and Vianna2 cultured a pleomorphic bacterium from the lesions and named it Calymmatobacterium granulomatis. However, in the following years there was a fierce controversy regarding the etiology of the disease and many conflicting views were expressed. In a review of the literature by McIntosh3 several interesting revelations were brought out. Randall et al were reported to have cultivated a bacillus from only three cases. They were identified as belonging to the Friedlander group. Wise et al were quoted as having found spirochetes on a direct smear from the lesion. Cornwell and Peck had reported isolation of a pleomorphic organism of a beaded morphology, which, when injected subcutaneously into rabbits, produced granulomatous lesions simulating donovanosis at the site of injection.
It is apparent from the preceding observations that there was considerable difference of opinion at that time regarding the etiology of the disease. Goldzeiher and Peck4 recognized the Donovan bodies in histological sections of the tissue. Their observations were the first of the kind and helped considerably in alleviating the existing doubts. However, their claims of cultivating an intracellular capsulated bacillus were as unconvincing as those of previous workers. Castellani et al5 clarified that inoculation of these cultures into animals could produce abscesses, but they fell short of causing lesions simulating granuloma inguinale. Thus the question raised by them was, “Were these really Donovan bodies which were being cultured?”. If they were, it would logically indicate that Donovan bodies could be nosoparasites, like Proteus X-19 in typhus, i.e. they would always be associated with lesions of the disease but would not themselves be the causative organisms.5
De Monbreun et al6 succeeded in isolating a bacillus of Aerogenes group from lesions as well as feces of patients with granuloma inguinale. They could demonstrate a morphological resemblance to Donovan bodies in culture but failed to transmit the infection to animals. They put forward the hypothesis that the disease was a chronic intestinal infection by the Aerogenes group of bacilli with secondary fecal contamination of the skin by these organisms. Prior to this observation, McIntosh3 was the first to achieve the successful transmission of the disease experimentally. He reported that Donovan bodies were the causative organisms of the disease and demonstrated changes in agglutinins, serum proteins ana skin sensitivity to suggest production of antibodies against the Donovan bodies. Until the end of the 1930s, the controversy regarding the nature of the etiological organism remained unsolved. Greenblatt et al7, were successful in producing granuloma inguinale in three human subjects. They were of the view that the Donovan bodies were sporozoans because of their affinity for mononuclear cells. Histological examination of lymph nodes revealed Donovan bodies, from which it was surmised that lymphatics could also be affected, in addition to subcutaneous tissue.
Anderson8 was able to achieve the culture of D. granulomatis on yolk sac of chick embryo. Later, Anderson et al9 described the process in details. They inoculated yolk sac of chick embryo with contaminant free human tissue from a case of granuloma inguinale. The first embryo with positive cultures was obtained after 17 days, having been inoculated 6 days previously. Serial cultures in 9, 10 or 11 days old embryos tended to produce unencapsulated organisms. Encapsulated organisms were produced if propagation was done on 4–6 days old chick embryos. On the basis of their successful culture of the organism, it was proposed that it should be given a new genus, and called it Donovania granulomatis. They were, however, unsuccessful in subculturing the organism on a wide variety of ordinary media, out found that addition of extracts of embryonic yolk or chick heart to melted infusion agar was successful in showing growth of the organism. The aforementioned attempts showed that previous so-called 6cultures of the Donovan microorganism were highly doubtful and were probably not of the organism itself but contaminants of some variety.
The culture of the Donovan microorganism was confirmed initially by Beveridge10 and other workers.1114 Encouraged by culture of D. granulomatis on yolk sac of chick embryo, efforts were made to discover an artificial medium for its cultivation. Only partial success was achieved by the adaption of Donovania granulomatis for cultivation of an artificial medium by Dunham and Rake.11 This contained beef heart infusion agar to which normal yolk of 6 days old embryos was added and this was transplanted on to slants prepared from 5 ml of 3 percent agar in tryptose beef heart infusion broth and 5 ml of modified Levinthal's stock broth. Following this, Goldberg et al15 were able to define and demonstrate the bacteriologic behavior of D. granulomatis. Goldberg16 pointed out that two factors namely a low O-R potential which can be achieved by a thioglycollate medium, and a factor(s) present in egg were necessary for the of D. granulomatis. The latter could be substituted by the enzymatic digest of bovine albumin or soya meal, Goldberg17 also succeeded in isolating a bacterium resembling D. granulomatis from the feces of a patient of granuloma inguinale. Subsequent publications18,19 postulated direct infection by a fecal organism. There are hardly any further reports on the culture of D. granulomatis after 1962 till date.
 
References
  1. Donovan C. Medical cases from Madras General Hospital-Ulcerating granuloma of the pudenda. Ind Med Gaz. 1905; JW: 414–415.
  1. Aragao H, Vianna G, Unter Suchungen Ueber das, granuloma venereum. Mein Inst Oswaldo Cruz. 1913;5:211–238.
  1. McIntosh JA. The etiology of granuloma inguinale. JAMA. 1926;87:996–1002.
  1. Goldzeiher MA, Peck SM. Virchows Arch Path Anat. 1926; 258:795.
  1. Castekkabu A, Mendelson RW. Remarks on the so-called “cultures of Donovan bodies”. J Trop Med Hyg. 1929;32:148–149.
  1. DeMonbreun WA, Goodpasture EW. Further studies on the aetiology of granuloma inguinale. Am J Trop Med. 1933;13:447–463.
  1. Greenblatt RB, Dienst RB, Pund ER, Torpin R. Experimental and clinical granuloma inguinale. JAMA. 1939;113:1108–1116.
  1. Anderson K, DeMonbreun WA, Goodpasture EW. An etiologic consideration of Donovania granulomatis cultivated from granuloma inguinale (three cases) in embryonic yolk. J Exp Med. 1945;81:25–40.
  1. Anderson K, Goodpasture EW, DeMonbreun Wa. Immunologic relationship of Donovania granulomatis to granuloma inguinale. J Exp Med. 1945;81:41–50.
  1. Beveridge WIB. Action of antimony and some other bacteriostatic substances on Donovania granulomatis isolated in chick embryo. J Immunol. 1946;53:215–222.
  1. Dienst RB. Laboratory diagnosis of granuloma inguinale and studies on the cultivation of the Donovan body. Am J Syph Gonorrhea Vener Dis. 1948;32:301–306.
  1. Dienst RB, Reinstein CR, Kupperman’ HS, Greenblatt RB. Studies on the causal agent of granuloma inguinale. Am J Syph. 1947;31: 614–617.
  1. Dunham W, Rake G. Culture and serologic studies on granuloma inguinale. Am J Syph Gonorrhea Vener Dis. 1948;32:145–149.
  1. Thomison JB. Primary isolation of Donovania granulomatis by chick brain inoculation and induction of cerebral miliary granulomata. Proc Soc Exp Bio Med. 1951;77:557–558.
  1. Goldberg J, Weaver RH, Packer H. Studies on granuloma inguinale I. Bacteriologic behaviour of Donovania Granulomatis. Am J Syph Gonorrhea Vener Dis. 1953;37:60–70.
  1. Goldberg J. Studies on granuloma inguinale IV. Growth requirements of Donovania granulomatis and its relationship to the natural habitat of the organism. Br J Vener Dis. 1959;35:266–268.
  1. Goldberg J. Studies on granuloma inguinale V. Isolation of bacterium resembling D. granulomatis from the faeces of a patient with granuloma inguinale. Br J Vener Dis. 1962;38:99–102.
  1. Goldberg J: Studies on granuloma inguinale VII. Some epidemiological considerations of the disease. Br J Vener Dis. 1964;40;140–145.
  1. Goldberg J, Bernstein R. Studies on granuloma inguinale VI. Two cases of perianal granuloma inguinale in male homosexuals. Br J Vener Dis. 1964;40:137–139.

Immunologychapter 3

Studies on the immunologic status of patients with granuloma inguinale really started alongwith the first attempts at culture of the organism. McIntosh1 had postulated antibody production against the Donovan microorganisms on the basis of agglutinins, precipitin changes in globulins and skin sensitivity in spontaneous and experimental cases studied by him. The definite immunological relationship of D. granulomatis to granuloma inguinale was demonstrated by Anderson et al.2 They used an antigen produced from their culture, and demonstrated positive skin tests in six cases of granuloma inguinale. Capsular material used by them was found to elicit distinct precipitation reactions in 18 out of the 19 cases; further, in the same study, complement fixation tests were positive in 12 out of the 15 cases of granuloma inguinale. Dunham and Rake3 reported 86 percent positivity in complement fixation tests, in 58 cases of granuloma inguinale. However, using the same antigen, they also demonstrated 12 percent positivity in patients with history of sexual exposure, but without the disease. Similarly, the test gave affirmative results in 21 percent of cases with nonspecific ulcers. Similar results of complement fixation tests occurred if antigen prepared from Klebsiella pneumoniae replaced that prepared from D. granulomatis. He, therefore, postulated that the organism causing the disease was, perhaps, derived from feces, and had a high degree of mutability, some strains growing only on yolk sac of chick embryo, while others grew on artificial media also. Using a similar antigen, Chen et al4 described skin reactions amongst patients with donovanosis and reported 100 percent positive skin reactions in these cases. They also obtained false positive reactions in 7 of the 28 controls. Skin reactions were observed to begin as early as two weeks following the onset of granuloma inguinale and persisted indefinitely thereafter. Packer and Dulaney5 demonstrated 83 percent positivity in complement 9fixation tests in patients with donovanosis. Skin tests were reported to be 70 percent positive, but clearcut interpretation was not possible, comprehensive studies on the immunology of D. granulomatis were, however, done by Goldberg et al.6,7 They used three antigens and showed positive complement-fixation tests in 136 of the 151 donovanosis cases. The duration of the lesion appeared to strongly influence the positivity of the test and directly proportional to it further, they established the antigenic heterogenicity of D. granulomatis for different results were obtained with the use of five different strains as antigens. In a subsequent study by Goldberg et al.8 It was reported that 9 out of 62 cases of squamous cell carcinoma of the penis tested with D. granulomatis antigens showed positive results, tending to strengthen the ‘association of donovanosis with squamous cell carcinoma of the penis.
Despite the above studies, no specific immunological, diagnostic test is as yet available for use in donovanosis. Rajam and Rangiah9 were of the firm conviction that the demonstration of D. granulomatis in tissue smears from active lesions still had the highest, and most reliable direct and specific diagnostic value, although a satisfactory immunological relationship between the organism and the disease is yet to be established.
 
References
  1. McIntosh JA. The etiology of granuloma inguinale. JAMA. 1926;87:996–1002.
  1. Anderson K, Goodpasture EW, DeMonbreun Wa. Immunologic relationship of Donovania granulomatis to granuloma inguinale. J Exp Med. 1945;81:41–50.
  1. Dunham W, Rake G. Culture and serologic studies on granuloma inguinale. Am J Syph Gonorrhea Vener Dis. 1948; 32:145–149.
  1. Chen CH, Dienst RB, Greenblatt RB. Skin reaction of patients to Donovania granulomatis. Am J Syph Gonorrhea Vener Dis. 1949;33:60–66.
  1. Packer H, Dulaney AD. Diagnostic tests in granuloma inguinale. Am J Syph Gonorrhea Vener Dis. 1949;33:68–72.
  1. Goldberg J. Studies on granuloma inguinale III. The antigenic heterogenicity of Donovania granulomatis. Am J Syph Gonorrhea Vener Dis. 1954;38:330–335.
  1. Goldberg J, Weaver RH, Packer H, Simpson WG. Studies on granuloma inguinale II. The complement fixation test in the diagnosis of granuloma inguinale. Am J Syph Gonorrhea Vener Dis. 1958;37:71–76.
  1. Goldberg J, Annamunthodo H. Studies on granuloma inguinale VIII. Serological reactivity of sera from patients with carcinoma of penis when tested with donovania antigens. Br J Vener Dis. 1966;42:205–209.
  1. Rajam RV, Rangiah PN. Donovanosis. World Health Organisation Monograph Series No. 24, 1954.

Epidemiological Featureschapter 4

 
Geographical Distribution
The disease is enemic in New Guinea, Central Australia and the Caribbean1 in some parts of West New Guinea; the incidence may be as high as 12.35 percent of the population. The disease is relatively uncommon among the Western races and is believed to be common in dark skinned races.2 Although earlier, there was a high incidence of the disease in parts of the USA,3 this is no longer true. However, sporadic reporting of the disease has been observed.4
In India donovanosis is endemic along the eastern seacoast, Madras and Orissa.5 Cutler et al6 reported that it was widespread throughout Himachal Pradesh; out of 1092 individuals screened by them, they detected 14 cases of donovanosis. There are only a few reports from Northern India Lal et al7 reported an incidence of 3.5 percent of the total venereal diseases in Delhi, while Sehgal and Prasad8 found that it constituted 3.14 percent of total cases. The latter study emphasized the necessity of a high index of suspicion in diagnosis of the disease especially in nonendemic areas. Sowmini et al9 in an interesting study postulated that climate had an influence on donovanosis in India they reported a high incidence of the disease from the states of Andhra Pradesh, Tamil Nadu and Mysore. These three states have a high temperature (23.9–32.2°C) throughout the year; the range of variation of tempreture is 9.4°C to 12°C and relative humidity of 50–70 percent. There was moderate rainfall of less than 100 cm per year. In contrast, Punjab, Himachal Pradesh, Madhya Pradesh, Rajasthan, and Jammu and Kashmir, which have extremes of temperature 0° to 17°C had low incidence of donovanosis. The authors thus concluded that moderate relative humidity and constantly high temperature were the influencing factors in the prevalence and pattern of the disease. 12
 
Incidence
Donovanosis is usually considered to be one of the minor venereal diseases, as it constitutes a low percentage of the total venereal diseases—its range being 0.3 to 6.3 percent of the total venereal diseases reported amongst the hospital population in India (See Table 4.1). An isolated paper, however, reported a percentage as high as 23.6.10
In a recent analysis of data of Lok Nayak Jai Parkash Narain (LNJPN) Hospital, New Delhi, donovanosis was established in 78 (7.16%) of the 1,090 genital ulcer cases. The percentage of donovanosis amongst the sexually transmitted diseases was 3.99 percent. Amongst genital ulcers the most common was chancroid (49.71%), followed by herpes progenitalis (16.90%), secondary syphilis (12.54%), primary syphilis (9.49%) and donovanosis (7.16%). Miscellaneous causes accounted for only 2.57 percent.
Table 4.1   Incidence of donovanosis from India
Author (s)
Region
Incidence (%)
Sardari Lal et al7
Delhi
3.5
Sehgal and Prasad8
Delhi
3.14
Khatri et al10
Jodhpur
23.6
Serma11
Guntur
2.58
Ayyangar12
Madurai
1.5
Rama Rao & Parnaik13
Kakinda
6.3
Ramachander et al14
Guntur
3.6
Sardari Lal et al15
Pondicherry
3.53
Vimla Bai et al16
Hyderabad
0.3
Secunderabad
0.9
Bedi et al17
Pondicherry
6.1
Sardari Lal & Nicholas18
Pondicherry
5.3
Anandam19
Kurnool
1.6
13
 
4.3 Age and Sex
The incidence of donovanosis is greatest from 20 to 40 years, a period of sexual maturiy.5,20 The author, however, found a large number of cases (82.04%) of donovanosis in the age group ranging between 11 and 30 years (Table 4.2).
Although earlier reports20 described a higher incidence of the disease in women, nowadays men are more frequently affected. Rajam and Rangiah5 diagnosed 562 females and 1,350 males as donovanosis cases in their series. More recent reports8,18 also indicate a preponderance of male patients. From other countries a similar age incidence has been reported.3,21,22 However, earlier reports23,24 are at variance with the recent studies25,26 regarding the sex distribution. The latter have shown a preponderance of the disease in men in the ratio of 2.3:1. In the author's study, the number of males was 68 (87.18%), while that of females was 10 (12.82%), the male/female ratio being 6.8:1.
 
Marital Status
The difficulty of accurately determining the marital status of women affected by the disease has been emphasized.5 Although a slight preponderance of married over unmarried women was found, yet a close investigation revealed many deserted wives, frequently exchanged mistresses and widows. Amongst males, the unmarried are likely to be affected more often by the disease.8 In our study of the 49, (62.82%) unmarried patients, 46 were males and 3 females.
Table 4.2   Age distribution
Age (years)
Number of cases (%)
0–10
Nil (0)
11–20
27 (34.62)
21–30
37 (47.44)
31–40
12 (15.38)
41–50
2 (2.56)
50+
Nil (0)
14
The remaining 27 married patients comprised 20 males and 7 females. Two males were widowers.
 
Place of Residence
As shown by the recent Lok Nayak Jai Parkash Narayan Hospital's data analysis, of the 78 patients, 74 (94.87%) cases were residents of Delhi, the majority coming from its urban parts.
 
Occupation and Income
Most patients in the author's study belonged to a low socioeconomic status. They comprised petty businessman, unskilled or semiskilled workers and laborers (Table 4.3), 34 (43.59%) cases having an income of less than Rs. 400 per month.
 
Education
The recent analysis indicates that 35 (44.87%) were illiterate, 9 (11.54%) had attended primary school, 13 (11.54%) had attended middle school and 17 (21.78%) had been educated up to high school. Only 4 cases were graduates.
Table 4.3   Occupations
Occupation
Number of cases
Percent
Businessman
15
(19.23)
Unskilled workers
12
(15.23)
Semiskilled workers
11
(14.10)
Laborers
10
(12.82)
Skilled workers
8
(10.25)
Housewives
8
(8.97)
Rickshaw pullers
5
(6.41)
Student
5
(6.41)
Government service
2
(2.56)
Farmer
2
(2.56)
Prostitute
1
(1.28)
Total
78
(100)
15
 
Source of Infection
The present analysis of the LNJP Hospital data revealed 49 (62.82%) patients had contracted the disease from prostitutes. Casual sexual contact was responsible in 13 (16.67%) while in 9 (11.53%) their spouse had transmitted the infection. History of sodomy was elicited in 7 (8.97%) males with perianal lesions, and promiscuity in 25. Extramarital contact was recorded in a single female and premarital in 2 females.
 
Incubation Period
Only a few sexually transmitted diseases show such wide variation in their incubation period as donovanosis (See Table 4.4). However, Sehgal and Prasad8 found the average incubation period in their study to be 17.39 days. Experimental infection of man with D. granulomatis has been attempted to accurately determine the incubation period.27 Such cases developed a full blown picture of the disease in 50 days. Cultured organisms when transplanted in a volunteer yielded Donovan bodies on smear examination from the site in 60 days.28 In the study conducted by the author its range was 3–90 days, with a mean period of 12.79 days (Table 4.5).
 
Duration of the Disease
Chronicity of the lesions was a marked feature in the earlier series but such a situation is infrequent now because of a greater emphasis on early diagnosis and a prompt, specific and adequate drug therapy. The duration of the disease varied from 6 days to 6 years in the recent data analysis. Only 9 patients applied for treatment 8–15 days after the formation of the lesion whereas 23 took three months to report. The average duration, however, was 152.1 days (Table 4.6). In the past the average duration was around 2.5 years.5, 20 16
Table 4.4   Range and average incubation period
Author (s)
Range (days)
Average (days)
Rajam & Rangiah5
1–84
18
Sardari Lal et al7
14–30
Sehgal & Prasad8
3–90
17.39
Khatri et al10
2–45
2–21
Ayyangar12
7–120
Rama Rao & Patnaik13
3–180
7–42
Ramachander et al14
1–360
7–30
Sardari Lal et al15
1–30
Vimla Bai et al16
30–360
Bedi et al17
3–60
3–00
Sardari Lal & Nicholas18
3–180
7–30
Anandam19
1–30
Niar & Pandalal20
1–84
18
Table 4.5   Incubation periods
Incubation period (days)
Number of cases
Percent
3–7
29
(50)
8–15
20
(34.48)
16–30
5
(8.62)
31–90
4
(6.90)
Total
58
(100)
The pattern of epidemics of donovanosis in the so-called nonendemic capital city of Delhi was studded.29 Of the 432 genital ulcer cases seen in 1985, 36 had donovanosis, thus forming an incidence of 8.33 percent. In contrast, 42 (6.38%) cases of donovanosis were diagnosed among a total of 658 cases of genital ulcers in 1983. The majority of patients in both epidemics were young unmarried men who contacted 17the disease through extramarital sexual intercourse.
Table 4.6   Duration of lesions
Duration
Number of cases
Percent
0–7 days
6
(7.69)
8–15 days
9
(11.54)
16–30 days
19
(24.36)
1–3 months
23
(29.49)
3–6 months
6
(7.69)
6 months–1 year
6
(7.69)
1–6 years
9
(11.54)
Perianal lesions were seen primarily in those who had a history of sodomy. The disease chiefly affected illiterate persons of low socioeconomic strata. The incubation period varied from 1 to 90 days. Twenty (62.50%) patients in the 1985 epidemic had an incubation period of less than 7 days, in contrast to only 9 (34.61%) in the 1983 epidemic. The epidemics occurred from autumn to the start of winter. Duration of the disease varied from 1 day to 6 years. The clinical features and sites of affliction were usual; however, pseudobubo and pseudoelephantiasis were conspicuous in a significant minority.
The interest in the entity seemed to have been magnified across the globe resulting in sporadic reporting of the condition from Toronto, Ontario, Canada30 and a lone case from China.31 Of the three reported from the former, two were immigrants, and one in native.
A comprehensive study with the objective to describe the epidemiological and clinical features of donovanosis, and their relevance to the possible coincident and risk of HIV-1 transmission in patients attending City Health STD Clinic, King Edward VIII Hospital, Durban, South Africa was done. In all there were 171 patients, in whom the diagnosis of donovanosis was made on the basis of detection of donovan bodies on tissue smears stained by RapiDiff technique. It had 130 men and 41 women. Ulcers were present for longer than 28 days in 72 18(55.4%) men and 19 (46.3%) women. 95 (55.6%) were from rural areas. Lesions were ulcerogranulomatous in 162, hypertrophic in 8, and necrotic in 1. Anal lesions were present in 1 woman. Only 1 of 21 regular sexual partners examined was found to be infected with donovanosis. Complete healing was recoded in 41 (24%) during follow-up. Extensive lesions were sometimes observed in pregnant women. Serological tests for syphilis were positive in 40 (23.4%). HIV-1 antibodies were detected in 4/48 men and 0/15 women. Donovanosis ulcers in 3 HIV-1 seropositive men were cured by standard antibiotic therapy. Delay in presentation, extensive areas of genital ulceration and lack of coexistent infection with donovanosis among sexual partners were notable features. Primary health care facilities in rural areas do not appear to be providing an adequate service for patients with donovanosis. HIV control program should consider specific measures aimed at eradicating donovanosis in areas where the condition is prevalent.32
 
References
  1. Halt G. Granuloma inguinale in principles and practice of infectious diseases. (Eds) Mandell GL, Douglas RG, Bennet JE, Wiley Medical School Publication,  1979; 1902.
  1. Goldberg J, Annamunthodo H. Studies on granuloma inguinale VIII. Serological reactivity of sera from patients with carcinoma of penis when tested with donovania antigens. Br J Vener Dis. 1966;42:205–209.
  1. Marmell M, Santora E. Donovanosis-granuloma inguinale, Incidence, nomenclature and diagnosis. Am J Syph Gonorrhea Vener Dis. 1950;34:83–90.
  1. Rosen T, Tschen JA. Ramsdell W, Moor J, Markham B. Granuloma inguinale. J Am Acad Dermatol. 1984;11:433–437.
  1. Rajam RV, Rangiah PN. Donovanosis. World Health Organisation Monograph Series No. 24, 1954.
  1. Cutler JC, Choudry KS, Tampi RB. Granuloma inguinale in the Himachal Pradesh, India. Med Illus. 1952;6:22–27.
  1. Lal S, Singh R, Sharma RC, Baruah MC. Donovanosis in North India. lnd J Derm Venereal Lepr. 1979;45:333–335.
  1. Sehgal VN, Prasad AL. A clinical profile of donovanosis in a non-endemic area. Dermatologica. 1984;168:273–278.
  1. Sowmini CN, Nair GM, Vasantha MNL. Climatic influence on the prevalence of donovanosis in India. Ind J Derrn Venereol Lepr. 1971;37:111–114.
  1. Khatri ML, Mathur NK, Kalla G. Clinico-epidemiological study of 26 cases of donovanosis. Ind J Derm Venereol Lepr. 1976;42:38–40.
  1. Serma JS. Granuloma vanereum—A problem in Guntur. Ind J Derm Venereol Lepr. 1957;23:9–15.
  1. Ayyangar MC. Granuloma venereum. A statistical study of 50 cases. J Indian Med Assoc. 1961;37:70–74.
  1. Rama Rao NSV, Patnaik R. Donovanosis at Kakinada (A clinical study). Ind J Derm Venereol Lepr. 1966;32:100–105.
  1. Ramachander, Jayalakshmi S, Pankaja P. A study of donovan os is in Guntur. Ind J Derm Venereol Lepr. 1967;33:237–241.
  1. Lal S, Padma NS, Velou A. Some clinical aspects of donovaosis. Ind J Dermatol Venereol. 1967;33:65–70.
  1. Vimala Bai K, Sulibhavi DG, Shyam Sunder P. A study of donovanosis. Ind J Derm Venereol Lepr. 1969;35:45–52.
  1. Bedi BMS, Garg BR, Sardari Lal, Nicholas C. Clinico-epidemiological study of 189 cases of donovanosis. Ind J Derm venereol Lepr. 1975;46:45–46.
  1. Lal S, Nicholas C. Epidemiological and clinical features in 165 cases of granuloma inguinale. Br J Vener Dis. 1970;46:461–463.
  1. Anandam K. Study of granuloma venereum. Ind J Derm Venereol Lepr. 1979;45:323–332.
  1. Nair VG, Pandalai NG. Granuloma genitoinguinale. Ind Med Gaz. 1934;39:361–372.
  1. Maddocks I, Anders EM, Dennis E. Donovanosis in Papua New Guinea. Br J Vener Dis. 1976;52:190–196.
  1. Davis CM. Granuloma inguinale—A clinical, histological and ultrastructural study. JAMA. 1970;211:632–636.
  1. Galloway J. Ulcerating granuloma of the pudenda. Br J Dermatol. 1897;8:13–20.
  1. Manson Bahr PH: Ulcerating granuloma of the pudenda, in Manson's Tropical Diseases, 16th edn. Cassel and Co. Ltd,  1967;n, 1637.
  1. King A, Nicol C, Rodin P: Granuloma inguinale in venereal diseases, 4th edn. The English Language Book Society and Balliere’ Tindall, 1980;pp.268.
  1. Stewart AB: Nontreponemal venereal infections in dermatology, Vol I. (Moschela SJ, Hurley HJ Eds), WB Saunders Co.  1985.
  1. Greenblatt RB, Dienst RB, Pund ER. Torpin R. Experimental and clinical granuloma inguinale. JAMA. 1939;113:1108–1116.
  1. Dienst RB, Reinstein CR, Kupperman HS, Greenblatt, RB. Studies on the causal agent of granuloma inguinale. Am J Syph. 1947;31: 614–617.
  1. Sehgal VN, Jain MK. Pattern of epidemics of donovanosis in the “nonendemic” region. Int J Dermatol. 1988;27:396–399.
  1. Hacker P, Fisher BK, Dekoven J, Shier RM. Granuloma inguinale: three cases diagnosed in Toronto, Canada. Int J Dermatol. 1992;31: 696–699.
  1. Gao Y, Ni K, Hu B, Zheng K. Granuloma inguinale: first case reported in the last four decades in China. Int J Dermatol. 1996;35: 758–759.
  1. O'Farrell N. Clinico-epidemiological study of donovanosis in Durban, South Africa. Genitourin Med. 1993;69:108–111.

Clinical Overtonechapter 5

 
Morphology
Earlier workers1,2 detailed the clinical features of the disease from the Indian subcontinent. Subsequently, there have been further studies312 on this aspect but Sehgal and Prasad13 in a recent study have clearly delineated the morphological variants, the details of which are being recounted.
The onset or the disease is marked by formation of a firm papule, which may erode to form an ulcer. The later may show variation in its morphology.
 
Ulcerative/Ulcer Granulomatous Variant
Most cases present as a single, well-defined, friable, beefy red, nontender, nonindurated ulcer with profuse granulation tissue, bleeding on touch, and showing no necrosis on the surface (Figs 5.1 to 5.8). However, atypical variants were encountered (Figs 5.9 and 5.10).
  1. Secondary infection of the ulcer caused it to become tender and develop necrotic slough on its surface. Associated tender regional lymphadenopathy also became apparent in these cases.
  2. About 28 cases presented with more than one lesion. In these cases, the ulcers were often infected secondarily. Their differentiation from chancroid became very important.
  3. Ulcers of longer duration have a tendency to spread slowly, leading to the formation of a well-marked raised margin at the edge of the ulcer. These cases often exhibited less granulation tissue. Chronicity of the ulcer sometimes caused a mild induration of the base of the ulcer; however, this may easily be differentiated from the “button-like” induration of a primary chancre.
22
 
Hypertrophic Variant
An irregular, friable raised growth bleeding on touch, or an ulcer with a well-defined raised edge and an elevated granulomatous base was the usual presentation (Figs 5.11 to 5.13 and 5.16). Two cases with unusual presentations were also seen in our study.
The first case presented with longstanding, slowly growing grayish-white, irregular, firm warty growths of the labia majora and mons pubis. The ‘lesions did not bleed on touch and were nontender. There was no lymphadenopathy. Donovan bodies were seen on tissue smears (Figs 5.14 and 5.15) after a prolonged search, but histopathology revealed a large number of histiocytes containing the donovan bodies.
The second case again presented with a chronic, slowly growing, grayish-white, irregular firm, warty growth on the glans penis. Inguinal lymph nodes were palpable. They were firm, nontender, discrete, mobile and bilaterally enlarged. Histopathology revealed changes of the pseudoepitheliomatous hyperplasia.
Fig. 5.1: A Well-defined, oval, nontender, nonindurated ulcer with everted edges on the under surface of the prepuce. (Courtesy: Sehgal and Prasad: Dermatologica, 1984;168:273-8)
23
Fig. 5.2: A typical ulcerative variant of donovanosis
Fig. 5.3: Ulcerative variant of donovanosis
24
Fig. 5.4: Ulcerative variant of donovanosis
Fig. 5.5: Granulation tissue pouting from the base, and well-defined, everted edges characterize the ulcer granulomatous variant
25
Fig. 5.6: Ulcerative variant of donovanosis
Fig. 5.7: Ulcerative variant of donovanosis
26
Fig. 5.8: Expression of ulcerative donovanosis on the fourchette in a female patient
Fig. 5.9: An atypical presentation of ulcerative variant presenting as a single, oval, mildly tender, slightly indurated ulcer with little granulation tissue on the undersurface of the prepuce (Courtesy: Sehgal and Prasad, Dermatologica, 1984;168: 273-8)
Fig. 5.10: An atypical ulcerative variant presenting as multiple ulcers simulating chancroid (Courtesy: Sehgal and Prasad, Dermatologica, 1984;168:273-8)
27
Fig. 5.11: Hypertrophic variant: tender, necrotic, well-defined lesion with irregular, everted margins over the perianal region (Courtesy: Sehgal and Prasad, Dermatologica, 1984;168:273-8)
Fig. 5.12: Exuberant, verrucous growth in the perianal area—hypertrophic variant of donovanosis
28
Fig. 5.13: Sparse, irregular, warty growth on the labia majora and mons pubis: An unusual manifestation of the hypertrophic variant
However, in the same section, donovan bodies were demonstrable in mononuclear cells.
 
Necrotic Variant
A single case of this type of donovanosis was seen. A large foul smelling, tender, nonindurated, irregular ulcer was present on the frenum. This was associated with a similar ulcer at the left inguinal region. These had developed rapidly within a few days and had caused some destruction of the genitalia donovan bodies were demonstrable on tissue smears and histopathological section.
 
Sclerotic Variant
One case of sclerotic type was seen. A single deep, undermined, nonbleeding edges, was present on preputial skin for 2 months. Sometimes it would become active and sometimes it showed 29partial healing, leaving behind a zone of depigmentation.
Fig. 5.14: Tissue smear depicting intra- and extracellular donovan bodies (Giemsa × 1000)
30
Fig. 5.15: Tissue smear showing intracellular Donovan bodies (Giemsa × 1000)
Fig. 5.16: Burst pseudobubo
31
Donovan bodies were seen in Giemsa stained tissue sections of this lesion.
Besides these, sometimes atypical forms of the disease may also be seen.
 
Pseudobubo
A true bubo is generally not formed in donovanosis. However, sometimes subcutaneous tissue of the groins is affected, probably through lymphatics, leading to a fluctuant swelling which has been named by Greenblatt et al,14 as pseudobubo. This swelling mostly ruptures forming a clean raised granulomatous ulcer.
Secondary infection of the lesions may cause the ulcer to become tender, and this may also be associated with tender lymphadenopathy. Multiple ulcerations, resembling chancroid, may occasionally be seen. The preceding cases may pose a diagnostic problem, which may warrant histopathological appraisal. A similar situation may arise in dry, verrucous growths in and around the genitalia.
 
Genital Lesions
They are predominantly involved in donovanosis1,2 the details of which are shown in Table 5.1. The prepuce, coronal sulcus, shaft, glans and frenum are the common sites of affliction in males, while in females, the labia minora, fourchette and labia majora are affected.13 Recounting the findings of the present analysis in males, the prepuce was affected in 31 (39.74%), coronal sulcus in 17 (21.79%), shaft of the penis in 7 (8.97%), glans and frenum in 4 (5.13%) each, while the inguinal region was affected in 3 and the upper thigh in 2 cases, labia minora in 4 cases, while the lesions were located on labia majora in 4 and in the perianal region in 1 case. In addition, affliction of the inguinal lymph nodes was seen in 41 cases. They were bilateral in 53.66% and unilateral in 46.34%. 32
Table 5.1   Frequency of genital and genitoinguinal involvement
Author
Genital
Genitoinguinal (%)
Sardari Lal et al15
92.9
Khatri et al6
110.0
Serma11
23
Rama Rao and Patnaik10
88
7.6
Sardari Lat et al8
87
4
Vimla Bai et al12
92.4
5.6
Bedi et al5
84.6
5.3
Sardarilal and Nicholas7
83
92.7
Large, fungating labial ulcers, labial swelling, vaginal discharge, rectovaginal fistulae and hematuria are a few of the clinical presentation of donovanosis in women. The diagnosis of the condition may be missed in favor of common presumptive diagnoses of carcinoma, herpes, syphilis and granuloma inguinale, should the diagnosis of donovanosis not suspected and investigated accordingly.16 Occasionally, extensive mutilating granuloma inguinale in women may be encountered, especially following rape.17 Perianal abscess and sinuses are known to occur in granuloma inguinale.18
Pseudoelephantiasis of the penis, an unusual sequel of longstanding donovanosis may also be seen.19
Pseudoelephantiasis and carcinoma of the cervix are the other unusual gynecological presentations of donovanosis, which should be taken cognizance in the course of clinical examination including tissue smear and histopathology.20 Genital elephantiasis (esthiomene), which is the dramatic end-result of lymphatic obstruction, is rather rare. Although mainly associated with filariasis and sexually transmitted diseases, such as lymphogranuloma venereum and donovanosis. This subject has been dealt with in requisite details elsewhere.21 In addition, it could also be an uncommon complication of tubercular lymphadenitis, a common infection in tropical countries. A rare 33case of a 32-year-old Indian female in whom genital elephantiasis occurred as a complication of tubercular lymphadenitis was reported.22
The simultaneous occurrence of two variants namely hypertrophic and ulcer granulomatous lesions during the 3rd trimester of pregnancy were described for the first time in the young Zulu women, when the patient presented at 36 weeks. The ulcerative lesions were located at the introitus, had raised edges, of 2 cm in diameter, while the dry keloidal-like 2 × 4 cm lesion was present in the inguinal region. This is yet another presentation which warrants attention. Of course, the diagnosis should be worked up through tissue smear and its salient histopathology characterized by mildly acanthotic surface squamous epithelium with underlying granulation tissue containing plasma cells, lymphocytes, pockets of neutrophils, and scattered histiocytic cells. Donovan bodies with the typical ‘safety pin’ appearance, demonstrated by a Giemsa stained tissue smear.23
At times an individual may report with asymptomatic painless penile ulcer, which may call for investigations (vide supra)24 to exclude other causes of GUD. Occasionally, GI may present as an uncommaon cause of destructive vulval lesion, the morphology of which may resemble that of fungating squamous cell carcinoma of the cervix. Giemsa stain tissue smear and histopathology may prove handy in its ultimate diagnosis.25 A hat-trick of ulcerating pathogens in a single genital lesion has been reported in a Jamaican heterosexual man known to have herpes, donovanosis and syphilis in a single genital ulcer, thus highlighting the significance of careful clinical assessment.26
An intriguing concomitant occurrence of malacoplakia and granuloma inguinale of the cervix in acquired immune deficiency syndrome was reported in two women, presenting with bloody, foul-smelling, vaginal discharge. The features of cervical ulceration conform to those of cervical carcinoma on per speculum examination. In addition, cervical punch biopsy from the lesion conform the characteristic features of GI, namely granulation tissue containing a dense plasma cell infiltrates, 34aggragates of neutrophils, and vaculated enlarged histocytes containing donovan bodies. Many of the histocytes and sheets of von Hansemann cells contaning intracytoplasmic Michaelis-Gutmann bodies, conforming the diagnosis of concomitant malacoplakia. Michaelis-Gutmann bodies were also present in extracellular locations. Ultrastructural examination confirmed the preceding histopathologic findings.27 An insight into this example and those presenting with a clinical picture of this type should thoroughly be investigated to arrive at the appropriated diagnosis.
Donovanosis is an acquired sexually transmitted disease predominantly affecting the external genitalia. The cervix is an uncommon site of involvement, and can clinically mimic carcinoma of the cervix. Magnetic resonance imaging (MRI) appearance of donovanosis has never been described previously as a diagnostic tool in donovanosis. It was recently undertaken in a case of cervical donovanosis and pointed out that the findings were indistinguishable from that of carcinoma of the cervix.28 Nevertheless, it is worthwhile and should form a part component of diagnostic procedures.
 
Extragenital
The perianal region can also be affected this usually follows homosexual contact. Bedi29 has reported an unusual case of perianal granuloma inguinale in a child, of nonvenereal transmission. At attention has been drawn to primary perianal perineo-crural postpederasty donovanosis recently as a site of affliction.30
Milton Marmell31 reported 10 cases of perianal donovanosis and listed 51 cases in literature till then. Goldberg and Bernstein32 had quoted Vegal's account of an epidemic of donovanosis among a tribe in Dutch New Guinea. Vegal had equated the high incidence of the disease in this tribe to the widespread practice of pederasty and uninhibited sexual practices indulged in by them.
Another site which may occasionally be affected by this disease is the oral cavity.33 An unusual case of donovan as is of 35the right lumbar region associated with a subcutaneous sinus tract has also been described.34
Granuloma inguinale has been reported to mimic squamous cell carcinoma, as well as sexually transmitted diseases. A rare case of extragenital granuloma inguinale that mimicked a soft tissue neoplasm in an 18-year-old pregnant woman who presented with cervical and labial ulcers is described. An elective cesarean section was performed, at which time a retroperitoneal mass that involved the right ureter was found. At frozen section, the mass had a xanthogranulomatous appearance consistent with a soft-tissue neoplasm. Special stains of the permanent sections revealed the pathognomic features of granuloma inguinale.35
A precise detail of history and clinical examination are described in 63-year-old Hispanic man from Peru who recently had immigrated to the United States presented with progressive weakness, weight loss, and recurrent abdominal pain and passing bright red blood per rectum. The diagnosis of rectal carcinoma was suspected. The biopsies of two lesions taken from the sigmoid colon showed granuloma inguinale (donovanosis). A computed tomographic (CT) scan of the abdomen revealed a large pre-sacral mass. A radiographically guided fine needle aspiration (FNA) of the presacral mass showed findings characteristic of granuloma inguinale.36 FNA, therefore appears to be a useful adjuvant for diagnosis of an unusual case of granuloma inguinale (donovanosis) presenting with a presacral mass that had the radiologic characteristics of a malignant tumor. Donovanosis may present as a pelvic mass mimicking ovarian cancer, a situation like this was diagnosed in a young women who had reported with postpartum abdominal pain. CT scan was found to be consistent with ovarian carcinoma. However, the section prepared from the biopsy revealed macrophages laden with eosinophilic bodies. Culture, histoplasma, and taxoplasma serologies were found to be negative. Accordingly, a diagnosis of pelvic donovanosis was made and successfully treated with azithromycin.37
Donovanosis (Granuloma inguinale) is an infectious disease, the effects of which are usually confined to the genital region. 36Various extragenital manifestations of the disease have been described. This report describes a case where the condition represented in the oral cavity some time after the apparently successful treatment of the genital lesion. Members of both the medical and dental profession serving the northern parts of Australia and adjacent tropical regions should be aware of the possibility of encountering this disease. Delay in its diagnosis may result in extensive tissue destruction and a potentially fatal outcome. Intensive antibiotic therapy followed by long-term follow-up is usually curative.38,39 This specific derivation is also valid for other regions of the world.
Granuloma inguinale (donovanosis) is predominantly seen in adults. However, it may rarely occur in children. It mainly affects genital skin and/or mucosa. Infection may occur at other parts of the skin and mucosa. Hematogenous dissemination to bone also has been described. The infection has a tendency to responds to appropriate antibiotic treatment. Two cases of granuloma inguinale occurring in 5 and 8 months old chills or on record, resulting in mastoiditis and external ear discharges. Subsequently, it resulted in temporal lobe abscess in an 8-month-old child. CT scans reveled marked improvement in the brain lesion after treatment. Whereas the 2nd child had a polypoid mass in the middle ear that on biopsy showed the features of granuloma inguinale. The mother of this child had biopsy-proven granuloma inguinale of the uterine cervix. This is a unique example of transmission of clamato-bacteria from the infected mother to a neonate, in the course of normal vaginal delivery.40 Careful cleansing of neonates born to such infected mothers is recommended to prevent the possible emergence of such an episode.
An extremely unusual case of primary extragenital donovanosis affecting the dorsa of right foot has been reported, emphasizing the clinical and histopathological features of the disease. The implications of absence of genital lesions, and consequent difficulty in diagnosis have been discussed.41
Intrapelvic donovanosis presenting as psoas abcess is indeed interesting and should be taken note of during the recourse of clinical examination.42 Disseminated granuloma inguinale 37with bilateral psoas abscesses is yet another reported case.43 Infection with Calymmatobacterium granulomatis is usually localized to the genital organs but rarely may be disseminated.
A case of granuloma inguinale (GI) presenting as a lateral neck mass in a 4-month-old, HIV-positive infant has been described.44 The histological features of the mass were typical of GI, with numerous macrophages containing intracellular organisms with a “closed-safety-pin” appearance. It is of rare occurrence, and the mode of transmission of infection is discussed. An awareness of GI in infants by both clinicians and pathologists is important to prevent morbidity and allow for prompt institution of appropriate treatment. Occasionally, cervical lymphadenopathy following donovanosis may be a presenting feature.45 The diagnosis in such cases should include demonstration of intra and/or extracellular donovan bodies in giemsa stain tissue smear. Histopathology may also be a useful adjunct.
 
References
  1. Nair VG, Pandalai NG. Granuloma genitoinguinale. Ind Med Gaz. 1934;39:361–372.
  1. Rajam RV, Rangiah PN. Donovanosis. World Health Organisation Monograph Series No. 24, 1954.
  1. Anandam K. Study of granuloma venereum. Ind J Derm Venereol Lepr. 1979;45:323–332.
  1. Ayyangar MC. Granuloma venereum. A statistical study of 50 cases. J Indian Med Assoc. 1961;37:70–74.
  1. Bedi BMS, Garg BR, Sardari Lal, Nicholas C. Clinico-epidemiological study of 189 cases of donovanosis. Ind J Derm venereol Lepr. 1975;41:1–3.
  1. Khatri ML, Mathur NK, Kalla G. Clinico-epidemiological study of 26 cases of donovanosis. Ind J Derm Venereol Lepr. 1976;42: 38–40.
  1. Lal S, Padma NS, Velou A. Some clinical aspects of donovaosis. Ind J Dermatol Venereol. 1967;33:65–70.
  1. Lal S, Nicholas C. Epidemiological and clinical features in 165 cases of granuloma inguinale. Br J Vener Dis. 1970;46:461–463.
  1. Ramachander, Jayalakshmi S, Pankaja P. A study of donovan os is in Guntur. Ind J Derm Venereol Lepr. 1967;33:237–244.
  1. Rama Rao NSV, Patnaik R. Donovanosis at Kakinada (A clinical study), Ind J Derm Venereol Lepr. 1966;32:100–105.
  1. Serma JS: Granuloma vanereum—A problem in Guntur. Ind J Derm Venereol Lepr. 1957;23:9–15.
  1. Vimala Bai K, Sulibhavi DG, Shyam Sunder P. A study of donovanosis. Ind J Derm Venereol Lepr. 1969;35:45–52.
  1. Sehgal VN, Prasad AL. A clinical profile of donovanosis in a non-endemic area. Dermatologica. 1984;168:273–278.
  1. Greenblatt RB, Dienst RB, Pund ER. Torpin R: Experimental and clinical granuloma inguinale. JAMA. 1939;113:1108–1116.
  1. Lal S, Singh R, Sharma RC, Baruah MC. Donovanosis in North India. lnd J Derm Venereal Lepr. 1979;45:333–335.
  1. Wysoki RS, Majmudar B, Willis D. Granuloma inguinale (donovanosis) in women. J Reprod Med. 1988;33:709–713.
  1. O'Farrell N. Mutilating granuloma inguinale after rape. A case report. S Afr Med J. 1989;76:72–73.
  1. Bondeson J, Bohe M, Carlsson U, Bjellerup M, Mikulowski P. Perianal abscess and sinuses caused by granuloma inguinale. Case report. Acta Chir Scand. 1989;155:607–610.
  1. Sehgal VN, Sharma HK. Pseudoelephantiasis of the penis following donovanosis. J Dermatol. 1990;17:130–131.
  1. Leung YC, McCartney AJ. Unusual gynaecological presentations of donovanosis as pseudo-elephantiasis and carcinoma of the cervix. Aust N Z J Obstet Gynaecol. 1990;30:172–175.
  1. Gupta S, Ajith C, Kanwar AJ, Sehgal VN, Kumar B, et al: Genital elephantiasis and sexually transmitted infections - revisited. Int J STD AIDS. 2006;17:157–165.
  1. Sarkar R, Kaur C, Thami GP, Kanwar AJ. Genital elephantiasis. Int J STD AIDS. 2002;13:427–429.
  1. O'Farrell N. Donovanosis (granuloma inguinale) in pregnancy. Int J STD AIDS. 1991;2:447–448.
  1. Golledge C. A painless penile ulcer. Aust Fam Physician. 1999; 28:605.
  1. Van der Griend B, Rane A, Green E. An uncommon cause of a destructive vulval lesion. Aust N Z J Obstet Gynaecol. 2001;41:459–460.
  1. Samuel M, Aderogba K, Dutt N, Lambert JS, Taylor C. A hat-trick of ulcerating pathogens in a single genital lesion. Int J STD AIDS. 2007;18:65–66.
  1. Ramdial PK, Sing Y, Chotey NA, Bagratee JS. Concomitant malacoplakia and granuloma inguinale of the cervix in acquired immune deficiency syndrome. Int J Gynecol Pathol. 2008;27:282–287.
  1. Taneja S, Jena A, Tangri R, Sekhon R. Case report. MR appearance of cervical donovanosis mimicking carcinoma of the cervix. Br J Radiol. 2008;81:e170–172.
  1. Bedi TR. Perianal granuloma inguinale in a child (non-venereal transmission). Ind J Derm Venereol Lept. 1980;116:45–46.
  1. Ghorpade A. Primary perianal perineo-crural postpederasty donovanosis. Int J Dermatol. 2007;46:855–857.
  1. Marmell M. Donovanosis of the anus in the male; an epidemiological consideration. Br J Vener Dis. 1958;34:213–218.
  1. Goldberg J, Bernstein R. Studies on granuloma inguinale VI. Two cases of perianal granuloma inguinale in male homosexuals. Br J Vener Dis. 1964;40:137–139.
  1. Garg BR, Lal S, Bedi BM, Ratnam DV, Naik DN. Donovanosis (granuloma inguinale) of the oral cavity. Br J Vener Dis. 1975;51: 136–137.
  1. Garg BR, Lal S, Bedi BMS, Tiwari KH, Arunthathi ‘S. Extragenital donovanosis (with subcutaneous sinus tract). Ind J Derm Venerol Lepr. 1971;44:227–228.
  1. Barnes R, Masood S, Lammert N, Young RH. Extragenital granuloma inguinale mimicking a soft-tissue neoplasm: a case report and review of the literature. Hum Pathol. 1990;21:559–561.
  1. Golfo EB, Galindo LM. Diagnosis of an unusual abdominal presentation of granuloma inguinale by fine needle aspiration cytology. Acta Cytol. 1990;34:570–572.
  1. Barroso LF, Wispelwey B. Donovanosis presenting as a pelvic mass mimicking ovarian cancer. South Med J. 2009;102:104–105.
  1. Doddridge M, Muirhead R. Donovanosis of the oral cavity. Case report. Aust Dent J. 1994;39:203–205.
  1. Veeranna S, Raghu TY. Oral donovanosis. Int J STD AIDS. 2002;13: 855–856.
  1. Govender D, Naidoo K, Chetty R. Granuloma inguinale (donovanosis): an unusual cause of otitis media and mastoiditis in children. Am J Clin Pathol. 1997;108:510–514.
  1. Rao MV, Thappa DM, Jaisankar TJ, Ratnakar C. Extragenital donovanosis of the foot. Sex Transm Infect. 1998;74:298–299.
  1. Mein J, Russell C, Knox J, Coppola A, Bowden FJ. Intrapelvic donovanosis presenting as a psoas abscess in two patients. Sex Transm Infect. 1999;75:75–76.
  1. West W, Fletcher H, Hanchard B, Rattray C, Vaughan K. Bilateral psoas abscess in a case of granuloma inguinale. West Indian Med J. 2005;54:343–345.
  1. Govender D, Hadley GP, Donnellan R. Granuloma inguinale (donovanosis) presenting as a neck mass in an infant. Pediatr Surg Int. 1999;15:129–131.
  1. Bowden FJ, Bright A, Rode JW, Brewster D. Donovanosis causing cervical lymphadenopathy in a five-month-old boy. Pediatr Infect Dis J. 2000;19:167–169.

Systemic Donovanosischapter 6

The dissemination of the disease to other parts of the body, such as the oral cavity, cheeks, eyelid, sternum, thorax, abdomen, lip, gums, pharynx, ribs and clavicles and colon may also occur.1
Metastatic lesions of donovanosis of bones have frequently been reported in comparison to other extragenital sites. Kirkpatrick et al,2 in a review of literature, found elevan other reports of bone lesions of donovanosis. All these cases except one, were females with lesions on the cervix. Osteolytic lesions are the usual presentation of donovanosis in the skeletal system.2,3 Rajam et al4 claimed to have reported the first case of systemic donovanosis from India, who had osteolytic lesions, along with a growth of the cervix uteri. Donovan bodies inside the liver cells were demonstrated in the tissue sections prepared from the liver biopsy.
Other unusual reported sites of involvement are the gingiva,5 uterus, tubes and ovary,6 buttock and lymph node7 and epididymis.8 In an extensive series of 2,000 patients9 extra-genital involvement was recorded in 6 percent cases. Sehgal et al10 presented an extremely rare case of primary extragenital disseminated cutaneous donovanosis. Disseminated granuloma inguinale secondary to cervical infection has also been reported recently.11 Besides, a case of disseminated donovanosis in a 54-year-old woman from northern Australia who had subsequent thoracic vertebral osteomyelitis and spinal cord compression has been described. Malignancy and vertebral tuberculosis were the major differential diagnoses. The patient had no genital lesions at the time of diagnosis of extragenital donovanosis but had undergone a hysterectomy, thus raising the possibility of prior disease of the uterine cervix (most previous cases have been associated with primary cervical disease). Despite treatment with doxycycline, she had no significant neurological improvement. Donovanosis disseminated to bone has been reported in 18 cases in the 42last 55 years. Awareness of donovanosis in the differential diagnosis of osteomyelitis and prompt pelvic examinations enabling early diagnosis of occult cervical disease are the most important measures in preventing morbidity and mortality due to disseminated donovanosis.12 Another case of disseminated donovanosis with cervical ulceration, massive pelvic lymphadenopathy, osteomyelitis of the wrists and septic arthritis of the knees and right elbow, was documented in a young girl of 23 years. The diagnosis of the conditions was conformed by histopathological examination of a specimen from colposcopic biopsy of the cervix uteri. She improved after several courses of antibiotics, blood transfusion, surgical debridement and aspiration of affected joints.13
 
References
  1. Eisenberg AA. Extragenital granuloma inguinale; report of a case. Am J Syph Gonorrhea Vener Dis. 1948;32:458–460.
  1. Kirkpatrick DJ. Donovanosis (granuloma inguinale): a rare cause of osteolytic bone lesions. Clin Radial. 1970;21:101–105.
  1. Sieber PE. Granuloma inguinale with bone involvement. Am J Roentgenol Radium Ther Nucl Med. 1965;95:515–517.
  1. Rajam RV, Rangiah PN. Donovanosis. World Health Organisation Monograph Series No. 24, 1954.
  1. Bhaskar SN, Jacoway JR, Fleuschaus PT. Oral surgery-oral pathology conference No. 15 Walter Reed Army Medical Center. Primary granuloma venereum of the gingiva. Oral Surg Oral Med Oral Pathol. 1965;20:535–541.
  1. Pund ER, Gotcher VA. Granuloma venereum (granuloma inguinale) of uterus, tubes and overies. Surgery. 1948;3:34–40.
  1. Jennison DB, Helwig EB, Milstone JH. Granuloma inguinale involving buttock and lymph nodes. Cultivation of the Donovan body in embryonic yolk. Arch Dermatol Syph. 1947;55:342–344.
  1. Jannach JR: Granuloma inguinale of the epididymis (case report). Br J Vener Dis. 1958;34:31–33.
  1. Rajam RV, Rangiah PN: Donovanosis. World Health Organisation Monograph Series No. 24, 1954.
  1. Sehgal VN, Sharma NL, Bhargava NC, Nayar M, Chandra M. Primary extragenital disseminated cutaneous donovanosis. Br J Dermatol. 1979;101:353–356.
  1. Cliff S, Wilson A, Wansborough-Jones M, Ash S. Disseminated granuloma inguinale secondary to cervical infection. J Infect. 1998; 36:129–130.
  1. Paterson DL. Disseminated donovanosis (granuloma inguinale) causing spinal cord compression: case report and review of donovanosis involving bone. Clin Infect Dis. 1998;26:379–383.
  1. 4:Fletcher HM, Rattray CA, Hanchard B, Vaughan K, West WM. Disseminated donovanosis (granuloma inguinale) with osteomyelitis of both wrists. West Indian Med J. 2002;51:194–196.

Associated Diseaseschapter 7

Concomitant infection with other sexually transmitted diseases is frequently seen. Primary syphilis (Fig. 7.1), lymphogranuloma venereum (Fig. 7.2) and gonorrhea are the most frequent associations.13 A reactive serology for syphilis in the absence of any clinical signs is occasionally demonstrated.4
 
Complications and Sequel
The most important sequela of donovanosis which has been studied quite extensively is its relationship to squamous cell carcinoma of the penis. Pund and Greenbl et al,5 in a histopathological study of the disease, found pronounced epithelial proliferation, simulating early epitheliomatous changes. Beerman and Sonck6 graded pseudoepitheliomatous hyperplasia seen in the disease into grades I, II and III, and concluded that when this extended deeply enough, a diagnosis of carcinoma penis could be made.
Fig. 7.1: Mixed infection—ulcerative donovanosis on the shaft, adjacent to a primary, chancre
45
Fig. 7.2: Lymphogranuloma venereum (LGV) with donovanosis, hypertrophic lesion of donovanosis on penis. “Groove” sign in the right inguinal region
Rajam and Rangiah7 have emphasized that the resemblance between donovanosis and carcinoma can be close, both on clinical and histological gounds. A true epitheliomatous change can occur as a complication or sequela to granuloma inguinale but seems to be an infrequent occurrence. The association of cancer of penis or cervix and granuloma inguinale appeared to be merely sequential without implication of causality.7
Stewart8 said unequivocally that carcinoma of the penis or vulva could be preceded by, or coexist with granuloma inguinale. Mackav and Bunch9 reported a case of carcinoma vulva following granuloma inguinale. Goldberg and Annamunthodo,10 took sera from 62 cases of squamous cell carcinoma of the penis and tested them with D. granulomatis antigens. They found positive reactivity in 9 cases, thus strengthening the clinical impression of association of granuloma inguinale with carcinoma penis.
Besides carcinoma, the other complications seen are adhesions to the scrotum and penis, destruction of the penile shaft, and pseudoelephantiasis.11 Stenoses of urethral, vaginal or anal orifices are complications of the sclerotic, variant of donovanosis. Metastatic lesions have also been reported (vide supra). 46
Fig. 7.3: Pseudoelephantiasis affecting the labia majora and the clitoris
Fig. 7.4: Pseudoelephantiasis of the penis
47
Pseudoelephantiasis is another unusual complication sparingly reported. It occurs both in males and females and is characterized by morphology simulating that of elephantiasis of the genitals. The differentiation from the latter is, however, made on the basis of conspicuous ulcer(s) of the donovanosis preceding the swellings (Figs 7.3 and 7.4) and absence of constitutional symptoms of fever, weakness and arthralgia. The mechanical obstruction of the lymphatics following the scar tissue may cause this condition.12
 
References
  1. Ayyangar MC. Granuloma venereum. A statistical study of 50 cases. J Indian Med Assoc. 1961;37:70–74.
  1. Sehgal VN, Prasad AL. A clinical profile of donovanosis in a non-endemic area. Dermatologica. 1984;168:273–278.
  1. Vimala Bai K, Sulibhavi DG, Shyam Sunder P. A study of donovanosis. Ind J Derm Venereol Lepr. 1969;35:45–52.
  1. Anandam K: Study of granuloma venereum. Ind J Derm Venereol Lepr. 1979;45:323–332.
  1. Pund ER, Greenblatt RB. Specific histology of granuloma inguinale. Arch Path. 1937;23:224–230.
  1. Beerman H, Sonck CE. The epithelial changes in granuloma inguinale. Am J Syph Gonorrhea Vener Dis. 1952;36:501–510.
  1. Rajam RV, Rangiah PN. Donovanosis. World Health Organisation Monograph Series No. 24, 1954.
  1. Stewart DB. The gynaecological lesions of lymphogranuloma venereum and granuloma inguinale. Med Clin N Am. 1964;48: 773–786.
  1. Mackay CR, Bunch WL Jr. Carcinoma of vulva following granuloma inguinale. Am J Syph Gonorrhea Vener Dis. 1952;36: 511–514.
  1. Goldberg J, Annamunthodo H. Studies on granuloma inguinale VIII. Serological reactivity of sera from patients with carcinoma of penis when tested with donovania antigens. Br J Vener Dis. 1966;42:205–209.
  1. Ayyangar MC. Granuloma venereum. A statistical study of 50 cases. J Indian Med Assoc. 1961;37:70–74.
  1. Sehgal VN, Jain MK, Sharma VK, Pseudoelephantiasis induced by donovanosis, Genitourinary Med. 1987;63:54–60.

Laboratory Diagnosischapter 8

 
Tissue Smears
Undoubtedly, smears from tissue (Appendices I and II) obtained from lesions of donovanosis are of considerable diagnostic importance. A full description of the organisms as seen in tissue smears, stained with Wright's stain was given by Cannefax.1 Besides, Giemsa's stain and a special stain composed of 1 percent pinacyanole in methyl alcohol2 have been used. The latter stains the nucleus blue and the capsule pink.
Donovan bodies are identified as mature and/or immature organisms, which are present inside the cytoplasm of mononuclear cells. These cells may exhibit vacuolation inside the cytoplasm. The mature organism is ovoid or bean shaped, varying from 1 to 1.5 μ in length and 0.5 to 0.7 μ in thickness, with a well-defined, pinkish material surrounding a blue bacillary body. In addition, it has a dark-blue chromatin inclusion arranged at the poles. The capsule may either remain unstained or stain bright pink. The morphology of the immature organism, on the other hand, may conform to coccoid, diplococcoid or bacillary, the size of which varies from 0.6 to 1.0 μ. The diplococcoid forms, in particular, are interesting, and resemble a ‘closed safety-pin’.
Tissue smears, though vital, cannot be over emphasized, for they may be negative in early and/or lesions of long durations.3 Besides, in necrotic and sclerotic variant, and also those resembling malignancy;4 a similar problem may be faced. This lacuna may easily be abridged by detailed histopathological examination of tissue sections and demonstration of Donovan bodies, an aspect highlighted by Sehgal et al.3 Furthermore, Slow-Giemsa (overnight) tissue section staining technique was recommended for confirming the diagnosis. Its step-by-step implementation has been outlined to insure affirmative outcome. It was found to be 100 percent successful in different clinical variants of donovanosis. This method, though 49time-consuming, is much superior to often used tissue smears, and should be employed for its ultimate confirmation.5 Cervical smear depicting intracellular organisms in donovanosis of cervix may yet be another useful procedures.6 A couple of other techniques namely may Grunwald-giemsa staining method and a rapid technique the RapiDif stain were made use of in 23 cases each. Although, these two techniques was found useful for conformation of diagnosis yet the latter was recommended for use especially in sexually transmitted diseases clinics in the developing world.7
 
Culture/Recovery of the Organism In Vitro
The causative organism, Calymmatobacterium granulomatis, was cultured for the first time by Kharsany et al in the year 1996.8 It was a break through achievement, which subsequently encourage and provided impetus to another worker9 for its replications. Culture of the organism has also been done in HEp2 cells.10 This aforementioned observation led to the development of use of polymerase chain reaction (PCR) diagnostic using a colorimetric detection system.11,12 Phylogenetic analysis confirms close similarities with the genus Klebsiella and a proposal made that C. granulomatis be reclassified as Klebsiella granulomatis comb nov.13
 
Histopathology
Earlier it was generally believe, that histopathological changes are nonspecific and not sufficiently characteristic to permit a diagnosis of donovanosis on tissue section. However, Pund and Greenblatt,14 focused pointed attention to its unique histopathology charatrized by (A) a massiveness of cellular reaction surcharged with plasma cells, (B) a paucity of lymphocytes, (C) a diffuse sprinkling as well as focal collections of polymorphs in papillae, (D) pseudoepitheliomatous changes, and (E) pathognomonic mononuclear cells, filled with intracytoplasmic cysts with darkly staining bodies. These features are to be taken cognizance for confirming the diagnosis, accordingly, Sehgal et al3 had, emphasized the 50distinctive histopathological features which were rather striking and affected the dermis as well as the epidermis.
The dermal changes were primarily inflammatory and consisted of a dense infiltrate, which was predominantly formed by large numbers of plasma and mononuclear cells throughout the dermis. In addition, histiocytes were seen in varying numbers. A few large cells containing cystic spaces, often with nuclei pushed to one side, and darkly staining inclusions (cells of Greenblatt) were conspicuous (Fig. 8.1). The number of neutrophils and lymphocytes was insignificant in most sections, Intracellular and extracellular Donovan bodies (Figs 8.1 and 8.2) were shown in 40 out of 42 tissue sections. They had different morphological features: Coccoid, coccobacillary, or bacillary. Mature forms surrounded by a capsule were seen in some sections. Donovan ‘bodies were easily identified in Giemsa stained tissue sections, but difficult to identify in hematoxylin and eosin (H & E) stained sections. Vascular changes such as dilatation, and/or proliferation, were predominant in 62 percent of the cases. Endothelial proliferation was a common feature, and proliferation of the tunica media was seen in a few cases.
Fig. 8.1: Tissue section showing collection of Donovan bodies and pathognomonic cell of Greenblatt (Giemsa × 1000)
51
Fig. 8.2: Tissue section showing massive inflammatory infiltrate comprising plasma and mononuclear cells. Vascular dilatation showing endothelial proliferation (H & E × 400) (Courtesy: Sehgal et al, British Journal of Venereal Diseases, 1984;60:45-7)
The tissue sections showed discontinuity in the epidermis, with ulcerations varying from mild to severe. Proliferation of the stratum spinosum (acanthosis), in the form of elongation of rete ridges (Fig. 8.3), was a constant feature of the hypertrophic variety, but was observed only in 19 cases of the ulcerative type of donovanosis. Pseudoepitheliomatous hyperplasia was seen only in tissue sections of the hyperplastic variety. There was no clear-cut evidence of malignancy in the form of horn pearls, atypia of individual cells, or numerous mitotic figures. However, in these sections, neutrophilic sprinkling of both the upper dermis, and the epidermis was seen in 18 sections. In only three cases was there a collection of neutrophils forming microabscesses in the epidermis (Fig. 8.4). The adnexae, fat, and muscle were conspicuously spared. In 4 sections, fibrosis of the lower dermis was also recorded.
Other special stains, besides Giemsa, have been used for demonstration of Donovan bodies in tissue section. These are Delafield's hematoxylin-eosin, dieterle's silver stain,15 and the Warthin-Starry stain. The organisms stain black with silver stains whereas they are seen as red bodies with Giemsa.16 Margolis17 opined that the diagnosis of granuloma inguinale from frozen sections stained with polychrome methylene blue 52was easier than conventional sections: Nayar et al18 studied the histopathological features in 27 cases of donovanosis and documented the various changes.
Fig. 8.3: Epidermal changes in the form of elongation of the rete ridges, with intense inflammatory infiltrate primarily of mononuclear cells (H & E × 160). (Courtesy: Sehgal et al, British Journal of Venereal Disease, 1984;60:45-7)
Fig. 8.4: Ulcer with microabscess formation (H & E × 400) (Courtesy: Sehgal et al. British Journal of Venereal Diseases, 1984;60:45-7)
53
The relative merits of tissue smears, paraffin sections and semithin plastic embedded sections in the diagnosis of donovanosis were evaluated. It was found to be negative/doubtful for the demonstrations of causative organisms by tissue smears and paraffin sections. However, semithin plastic sections provided definite diagnosis. It has also reveal the organisms in epidermis and perivascular locations. From amongst the three stains: toluidine blue, Leishman's and thionine azure II basic fuchsin, the last mentioned was found to be the method of choice for demonstrating the organisms differently from the host cells.19
The aforementioned study was extended to include 65 patients of donovanosis for characterization of circulating lymphocytes by monoclonal antibodies. 53 of them belong to ulcerogranulomatous, while 10 of hypertrophic, and 2 of sclerotic, the hematological profile and quantitation of circulating blood lymphocyte was studied with monoclonal antibodies and an indirect immunofluorescence technique to assess the immunological under-currents of the disease. The ulcerogranulomatous variant had increases in both total and absolute lymphocyte counts. Total T-lymphocytes, CD4, CD8, CD22 and CD4/CD8 ratio was all significantly elevated. The hypertrophic variant, in contrast, showed a significant elevation only in the CD4/CD8 ratio.20
Moreover, tissue level lymphocyte subpopulations comprising total T-, B-, T4- and T8-lymphocyte were estimated in tissue sections of ulcers from 22 donovanosis patients, of which 17 were ulcerogranulomatous, 4 hypertrophic, and 1 sclerotic variants, using monoclonal antibodies and immunohistochemical technique (PAP). T- and B-lymphocytic infiltrations in the tissues were almost identical, without any significant difference in ulcerogranulomatous and hypertrophic variants. The T4:T8 ratio in ulcerogranulomatous variants, however, was 1.41, which was significantly higher than that of hypertrophic variants (1.28), indicating a greater 54cell-mediated immune response in the former than in the latter. This was substantiated by the documentation of a paucity of Donovan bodies, both in the tissue smear and slow (overnight) Giemsa-stained tissue sections,21 in the ulcerogranulomatous variant.22
Besides, an endeavor to estimate the frequencies of Human leukocyte antigens (HLAs) in patients of donovanosis and controls was made. HLA Class I, Class II and DQ antigens were detected in patients with genital ulceration caused by donovanosis and in a control group in a skin and STD clinics. A possible link between donovanosis and HLA B57 could be explained by coexisting alleles or immune response genes in linkage disequilibrium altering disease susceptibility.23
 
Labortary Diagnosis of Human Immunodeficiency Viruses Infection
Genito-ulcerative diseases (GUD) including donovanosis are vulnerable to contract Human immunodeficiency virus (HIV)/Acquired immunodeficiency syndrome (AIDS). It is therefore pertinent to subject such candidates to exclude the diagnosis. The later revolves around (I) serology, (II) virus isolation, (III) demonstration of viral NA, (IV) prognostic tests and (V) antiviral susceptibility assays.
 
Serology
The diagnosis of HIV infection by and large is made on the bases of serological tests:
 
Antibody Tests
Screening of blood samples for HIV antibody are commonly done by Enzyme-linked immunosorbent assays (ELISAs) the sensitivity and specificity of which is cent percent. However, false positive and negative do occur. Accordingly, passive particle agglutination, immunofluorescence, Western blots and radioimmunopercipitation assay (RIPA) bioassays are acceptable alternative currently in vogue. Western blots, gold standard, are the most accurate for they are capable of detecting the 55antibodies against both the env and egg proteins. Moreover, it is pertinent to point out that HIV antigen can be detected early in the course of HIV infection before the appearance of antibody, the latent period, when antigen-antibody complexes are present. The sensitivity of the test systems are currently being improved by the use of recombinant antigens.
 
Virus Isolation
It is primarily used for the characterization of the virus. The virus isolation is achieved either by the cocultivation of the patients’ lymphocytes with fresh peripheral blood cells of healthy donors or with suitable culture lines such as T-lymphomas. The presence of the virus can be confirmed by reverse transcriptase assays, serological tests, or by changes in growth pattern of the indicator cells. The process is tedious and time consuming, and is successful in only 70 to 90 percent.
 
Demonstration of Viral NA
This may either be accomplished by probes or by polymerase chain reaction (PCR) techniques. The latter may be useful because of its extremely high sensitivity. The latter is preferred because of its high sensitivity.
 
Prognostic Tests
Human immunodeficiency virus (HIV) antigen detection, serial CD4 counts, neopterin, B2-microglobulin and viral load are a few being used for evaluating the prognosis.
 
Antiviral Susceptibility Assays
Currently, it is considered useful, because of the advent of increasing range of anti-HIV agents available for use. Phenotypic and genotypic are well-recognized for the purpose. The former assist in identifying whether a particular strain of virus is sensitive or resistant to an antiviral agent by determining the concentration of the drug needed to inhibit the growth of virus in vitro. However, phenotypic assays can only be used for viruses that can be cultivated. Whereas, genotypic assays, mutations that are associated with resistance strains of virus 56are done by PCR and LCR. However, they are tedious and are not suitable for a routine diagnostic laboratory.
 
Other Diagnostic Modality
A couple of other diagnostic tools such as computerized tomography (CT)2426 scan and magnetic resonance imaging (MRI)27 to establish the diagnosis of a mass resulting from Calymmatobacterium granulomatus in the genital or extragenital regions have been made use of recently, the briefs of which have been indicated at a relevant place in the text.
 
Ultrastructure
Recent studies have been done by means of the electron microscope on the structure of Calymmatobacterium granulomatis. It has been found to have a capsular structure surrounding the bacterium. The other layer of the bacterial cell wall was corrugated, and internal to this was a narrow cytoplasmic membrane. Dense, homogeneous, peripherally located cytoplasmic inclusions 40 millimicrons in diameter, suggestive of a bacteriophage were a regular feature.28,29 These studies suggest a relation to Klebsiella group of organisms. These findings have been confirmed.30,31 Both the latter workers disputed the fact that there were bacteriophages present on the cell wall.
The research on this specific topic is continuing. However, because of the paucity of clinical material, it is confined to intermittent reports. A few of them are being reproduced currently.
In an ultrastructural study undertaken on donovanosis, the inflammatory response was studied along with the fine structure of causative organisms, Calymmatobacterium granulomatis. Macrophages were seen to be activated and showed presence of numerous filopodia and increase in the number of lysosomes and rough endoplasmic reticulum. Many cells had showed vacuoles of varying size in the cytoplasm some of which contained the organisms. Other cells seen included plasma cells, polymorphonuclear cells and sparse 57lymphocytes. In one case few multinucleated giant cells and dendritic cells with long cytoplasmic processes making cell-cell contact with other inflammatory cells were seen. Such cells have not been described in donovanosis so far. The organisms showed surface structures like pili and vesicles, the role of which is yet to be clearly understood.32
Ultrastructural study of C. granulomatis, the causative organism of donovanosis (granuloma inguinale), in human tissue revealed the presence of a complex cell envelope. The cytoplasm of these organisms showed presence of electron dense polar material, in addition to regular bacterial structures like mesosome, ribosomes, and nuclear material. Surface appendages, fimbriae and blebs were studied in detail. Origin of these structures was clearly endogenous to the cell wall. Morphology of fimbrium at the site of its attachment to the cell membrane has been described. A distinct layer of homogenous material of varying density surrounding the organism indicated the possibility of it being a capsule.
The morphological structure of Calymmatobacterium granulomatis, the organism responsible for donovanosis, was investigated in biopsy material from 15 patients. The use of human material was necessary because this organism is difficult to grow in artificial culture media. 1–10 organisms per cell from 1.5–2.5 mcm in size were observed singly or in clusters, most frequently in the vacuolated cytoplasm of macrophages in the upper portion of the dermis. Most notable was the limitation of these organisms by a complex cell envelope comprised of at least 2 layers—the corrugated cell wall and the cytoplasmic membrane. In most cases, the protoplasm was enclosed by more than 2 trilaminar membranes. Cytoplasm at the periphery contained ribosomes and fine membranes, while the nuclear materials tended to be located in the cell's center. The organism's surface was covered with multiple filamentous processes (fimbriae) and round vesicles (blebs). Unique to this study was the finding of electron dense polar bodies at poles. The basal portion of the fimbriae was more electron dense than the remaining portion. Also notable was the observation that fimbriae are attached to the inner membrane and do not arise 58from the cell wall. The blebs also appeared to be endogenous to the cell wall and could be seen detaching and moving away from the parent organism. Finally, a distinct layer of homogenous material was observed on light microscopy to surround the organism and is postulated to represent capsular material.33
In another study,34 the ultrastructural features of cells of Calymmatobacterium granulomatis from monocyte cocultures and tissue biopsy specimens were compared. In cultures the bacteria were mainly extracellular, i.e. not within membrane-bound vacuoles. The bacterial body was surrounded by a uniformly extensive homogeneous layer with a relatively high electron density. This layer varied considerably in tissue biopsy specimens, having either homogeneously electron-dense or delicate web-like structures with varying density and thickness. In tissue specimens the bacteria were located predominantly within vacuoles of varying sizes in the cytoplasm of the macrophages and, occasionally, extracellularly within the intercellular spaces of the stroma. The bacterial cytoplasm contained ribosomes scattered throughout with electron-dense granules located peripherally. The trilaminar cell-wall structure was typical of a gram-negative organism, comprising an outer membrane, a middle electron opaque layer and an inner plasma membrane. Surface structures such as fimbriae, flagella and bacteriophages were not identified in specimens from either source.
 
References
  1. Anandam K. Study of granuloma venereum. Ind J Derm Venereol Lepr. 1979;45:323–332.
  1. Greenblatt RB, Dienst RB, West RM. A simple stain for Donovan bodies in diagnosis of granuloma inguinale. Am J Syph Gonorrhea Vener Dis. 1951;35:291–293.
  1. Sehgal VN, Shyamprasad AL, Beohar PC. The histopathological diagnosis of donovanosis. Br J Vener Dis. 1984;60:45–47.
  1. Rajam RV, Rangiah PN. Donovanosis. World Health Organisation Monograph Series No. 24, 1954.
  1. Sehgal VN, Jain MK. Tissue section Donovan bodies–identification through slow-Giemsa (overnight) technique. Dermatologica. 1987;174:228–231.
  1. Chandra M. Cervical smear with intracellular organisms from a case of granuloma venereum (donovanosis). Acta Cytol. 1991;35: 143–145.
  1. O'Farrell N, Hoosen AA, Coetzee K, van den Ende J. A rapid stain for the diagnosis of granuloma inguinale. Genitourin Med. 1990; 66:200–201.
  1. Kharsany AB, Hoosen AA, Kiepiela P, Naicker T, Sturm AW. Culture of Calymmatobacterium granulomatis. Clin Infect Dis. 1996;22:391.
  1. Kharsany AB, Hoosen AA, Kiepiela P, Naicker T, Sturm AW. Growth and cultural characteristics of Calymmatobacterium granulomatis-the aetiological agent of granuloma inguinale (Donovanosis). J Med Microbiol. 1997;46:579–585.
  1. Carter J, Hutton S, Sriprakash KS, Kemp DJ, Lum G, et al: Culture of the causative organism of donovanosis (Calymmatobacterium granulomatis) in HEp-2 cells. J Clin Microbiol. 1997;35:2915–2917.
  1. Carter J, Bowden FJ, Sriprakash KS, Bastian I, Kemp DJ. Diagnostic polymerase chain reaction for donovanosis. Clin Infect Dis. 1999; 28:1168–1169.
  1. Carter JS, Kemp DJ. A colorimetric detection system for Calymmatobacterium granulomatis. Sex Transm Infect. 2000; 76:134–136.
  1. O'Farrell N. Donovanosis. Sex Transm Infect. 2002; 78: 452–457.
  1. Pund ER, Greenblatt RB. Specific histology of granuloma inguinale. Arch Path. 1937;23:224–230.
  1. Greenblatt RB, Barfield WE. Newer methods in diagnosis and treatment of granuloma inguinale. Br J Vener Dis. 1952;28:123–128.
  1. Lever WF, Schaumberg-Lever G: Granuloma inguinale, in Histopathology of the Skin 5th edn. J B Lippincott Co.,  Philadelphia, 1975.pp.290.
  1. Margolis G. The diagnosis of granuloma inguinale from frozen sections stained with polychrome methylene blue. Am J Path. 1945;21:543–548.
  1. Nayar M, Chandra M, Saxena HM, Bhargava NC, Sehgal VN. Donovanosis-A Histopathological study. Indian J Pathol Microbiol. 1981;24:71–76.
  1. Jain AK, Chandra M, Ganguli DD, Bhargava NC. Utility of semithin sections in the diagnosis of donovanosis. Indian J Med Res. 1989;90:270–274.
  1. Sehgal VN, Sharma HK, Sharma VK. Characterization of circulating lymphocytes by monoclonal antibodies in donovanosis. J Dermatol. 1991;18:181–183.
  1. Sehgal VN, Jain MK. Tissue section Donovan bodies—identification through slow-Giemsa (overnight) technique. Dermatologica. 1987;174:228–231.
  1. Sehgal VN, Gupta MM, Jain VK. Tissue level lymphocyte subpopulations in donovanosis. Int J Dermatol. 1991;30:857–859.
  1. O'Farrell N, Hammond M. HLA antigens in donovanosis (granuloma inguinale). Genitourin Med. 1991;67:400–402.
  1. Golfo EB, Galindo LM. Diagnosis of an unusual abdominal presentation of granuloma inguinale by fine needle aspiration cytology. Acta Cytol. 1990;34:570–572.
  1. Barnes R, Masood S, Lammert N, Young RH. Extragenital granuloma inguinale mimicking a soft-tissue neoplasm: a case report and review of the literature. Hum Pathol. 1990;21:559–561.
  1. Barroso LF, Wispelwey B. Donovanosis presenting as a pelvic mass mimicking ovarian cancer. South Med J. 2009;102:104–105.
  1. Taneja S, Jena A, Tangri R, Sekhon R. Case report. MR appearance of cervical donovanosis mimicking carcinoma of the cervix. Br J Radiol. 2008;81:e170–172.
  1. Davis CM. Granuloma inguinale—A clinical, histological and ultrastructural study. JAMA. 1970;211:632–636.
  1. Davis CM, Collins C: Granuloma inguinale: an ultrastructural study of Calimmatobacterium granulomatis. J Invest Dermatol. 1969;53:315–321.
  1. Nayar M, Chandra M, Saxena HM, Bhargava NC, Sehgal VN. Donovanosis—A Histopathological study. Indian J Pathol Microbiol. 1981;24:71–76.
  1. Nelson RA. Penicillin in the treatment of granuloma inguinale. Am J Syph. 1949;28:611–614.
  1. Chandra M, Jain AK, Ganguly DD, Sharma AK, Bhargava NC. An ultrastructural study of donovanosis. Indian J Med Res. 1989; 89:158–164.
  1. Chandra M, Jain AK. Fine structure of Calymmatobacterium granulomatis with particular reference to the surface structure. Indian J Med Res. 1991;93:225–231.
  1. Kharsany AB, Hoosen AA, Naicker T, Kiepiela P, Sturm AW. Ultrastructure of Calymmatobacterium granulomatis: comparison of culture with tissue biopsy specimens. J Med Microbiol. 1998; 47:1069–1073.

Differential Diagnosischapter 9

The diagnosis of donovanosis may appear simple should the ‘suspicion’ about the condition be adopted as the mainstay for ulcers over the genitalia all the same, at times, other conditions may also have to be considered. Such conditions, may, for the purpose of comprehension, may either be sexually transmitted diseases (STDs)/Sexually transmitted infections (STIs), or Non- Sexually transmitted diseases.
 
Sexually Transmitted Diseases
 
Chancroid
Chancroid is characterized by multiple, small, superficial, painful, dirty, necrotic ulcers of varying sizes (Fig. 9.1). The edges of the ulcers are undermined and surrounded by a narrow zone of erythema and edema. They are tender and bleed on touch. Inguinal bubo may be its accompaniment (Fig. 9.2). Usually it is unilateral, unilocular, fluctuant tender swelling with overlying taut and erythematous skin.
Incubation period varies from 2 to 7 days.
Dwarf chancroid (Fig. 9.3) is characterized by a small superficial ulcer. Giant chancroid is a large granulomatous ulcer in consequence to a ruptured bubo extending to involve the surrounding skin, follicular chancroids are seen in association with the hair follicles, while the serpiginous chancroids are characterized by multiple ulcer coalescing to form a serpiginous pattern. Its phagedenic variant (Fig. 9.4) may cause extensive destruction of the genitals associated with a foul-smelling discharge.
Demonstration of Haemophilus ducreyi in Gram-stained smear is diagnostic. Recovery of the organisms in vitro is imperative. Differentiating features of donovanosis and chancroid are given in Table 9.1. 62
Fig. 9.1: Chancroid involving coronal sulcus and groin
Fig. 9.2: Chancroid with bubo
63
Fig. 9.3: Dwarf chancroid—two circular, necrotic, tender, nonindurated ulcers on coronal sulcus and inner surface of the prepuce
Fig. 9.4: Phagedenic chancroid
64
Table 9.1   Differential diagnosis – donovanosis vs chancroid
Donovanosis
Chancroid
1. Causative agent:
Calymmatobacterium
granulomatis
Haemophillus ducreyi
2. Incubation period:
3 to 90 days
2 to 7 days
3. Morphology:
Fleshy exuberant, beefy-red, nonindurated, nontender, single elevated granulomatus ulcer with rolled over edges, which bleeds profusely on touch
Necrotic, small superficial, dirty multiple, tender, nonindurated ulcers with undermind edges, surrounded by erythematous halo. Dwarf, giant, follicular, serpiginous and phagedenic are its variants
4. Inguinal lymphadenitis:
Conspicuous absent
Inguinal bubo, if present, is unilateral, unilocular fluctuant and tender with overlying tout and erythematous skin
5. Tissue smears:
The demonstration of intracellular Donovan bodies, in mononuclear cells in Giemsa stained tissue smears and section is diagnostic
Demonstration of gram-negative rods with bipolar condensation of chromatin, arranged in parallel short chains like school of fish in Gram-stained smears is diagnostic
 
Chancroidal Ulcers (Fig. 9.5)
They have recently been defined.1 They are single ulcers with the morphology of chancroid. They have a longer incubation period of 8 to 11 days and show an absence of lymphadenopathy. Modern culture techniques2 which can be used to isolate H. ducreyi in a majority of chancroid cases fail to demonstrate the organism from chancroidal ulcers. Instead, a polymicrobial flora may be lsolated.3
 
Herpes Genitalis
Only rarely can this viral infection (Fig. 9.6) be mistaken for donovanosis. It presents classically as grouped vesicular lesions 65on an underlying erythematous base.
Fig. 9.5: Chancroidal ulcer—a solitary ulcer with morphology of chancroid on coronal sulcus
Fig. 9.6: Herpes progenitalis—multiple, polycyclic erosions on glans penis
The vesicles quickly rupture in a day or two to form superficial tender, polycyclic erosions on the genitalia. There may be a long history of recurrences and remissions. In early cases, scraping the floor of a vesicle gently with a scalpel, taking the material on a clean glass slide, and staining with Giemsa's stain, reveals characteristic 66multinucleated giant cells in the smear. Cell culture techniques are used to isolate the causative virus. The condition heals spontaneously.
 
Syphilis
 
Early Syphilis Comprises Primary and Secondary Stages
Primary chancre characterizes the primary stage (Fig. 9.7). Incubation period varies from 9 to 90 days. It is a painless, erythematous, indurated papule which gets eroded to form an ulcer. The ulcer is painless, clean, well-defined, indurated and has a raw exuding surface. It resembles a button glued to the skin or the mucous membrane (Fig. 9.8). It affects the coronal sulcus, undersurface of the prepuce, the glans, the prepucial orifice, shaft of the penis and the scrotum in males while in females labia majora, labia minora, the clitoris, the fourchette, the cervix, the vagina and the mons veneris are involved.
Fig. 9.7: Primary chancre—two indurated, nontender ulcers, with clean base, oozing serum, located on coronal sulcus and shaft of penis
67
Extragenital lesions are seen on the lips, the breast, abdomen, thighs and the anus. Lymphadenopathy characterized by multiple, nontender, discrete, firm and mobile glands is vital component and affects the inguinal glands on both sides. Demonstration of Treponema pallidum the causative organism, under the dark ground microscope is confirmatory (Table 9.2).
Secondary stage is recognized by an asymptomatic, polymorphic, bilateral and symmetrical rash, mucous patches, snail track ulcers and generalized lymphadenopathy with the classical features discussed above. Distinct clinical variants comprising syphilides of various, morphology namely macular, papular, pustular, follicular, annular, psoriasiform and condylomata lata may be found. The condylomata lata, in particular, are quite frequent and are evident as flat-topped, greyish white eruptions with oozing of serum, and seen primarily on the genitals, anus and the axillae. Demonstration of Treponema pallidum from the secondary lesions is confirmatory.
Fig. 9.8: Primary chancre on glans penis
68
Table 9.2   Differential diagnosis of donovanosis vs primary chancre
Donovanosis
Primary chancre
1. Causative agent
Calymmatobacterium
granulomatis
Treponema pallidum
2. Incubation period
3–90 days
9–90 days
3. Morphology
Fleshy, exuberant, beefy-red, nonIndurated, nontender, single elevated granulomatous ulcer which bleeds on touch
A clean button-like, markedly indurated, nontender, single ulcer which oozes serum
4. Inguinal lymphadenitis
Conspicuously absent
Characteristic rubbery, discrete, mobile, nontender and bilateral
5. Course of the ulcer Chronic and slowly progressive
Heals within 4 weeks, even without treatment
6. Diagnosis
Demonstration of Donovan bodies in Giemsa-stained tissue smears and sections is diagnostic
Demonstration of spiral sluggishly motile, brilliantly bright Treponema pallidum from ozzing serum in dark-ground microscopy, is confirmatory
 
Late (tertiary) Syphilis
This stage is rarely seen now-a-days. The ulcerative variety has a punched out appearance, with sharp vertical edges and a dull-gray “wash-leather slough” base. The nodular and psoriasiform type are unlikely to be mistaken for donovanosis.
 
Lymphogranuloma Venereum (LGV)
Donovanosis and LGV are morphologically distinct from each other. However, the earlier nomenclature (granuloma venereum vs lymphogranuloma venereum), may be a cause of some confusion. LGV presents initially as transient, herpetiform vesicular lesions on the genitalia which heal within a week. Around 2–8 weeks later, the patient has inguinal lymphadenitis and constitutional manifestations. The adenitis is multilocular, tender and non-fluctuant. The overlying skin is usually normal 69unless suppuration occurs, when multiple discharging sinuses are formed. Lymph nodes above and below the inguinal ligament are involved in giving rise to the typical “groove sign” with the inguinal ligament appearing as a groove in between the two lymph node masses (Fig. 9.9). A positive intradermal Frei-test and the modern serological techniques of complement fixation and microimmunoassay further differentiate LGV from donovanosis. Chlamydia trachomatis, the causative organism, may also be cultured from material taken from a bubo, or from the genital.
The late manifestations of LGV (Fig. 9.10) due to lymphatic obstruction, may be very similar to those seen in donovanosis inducted pseudoelephantiasis. The former, however, is considerably more common. Elephantiasis, leading to enormous hypertrophy of the genitalia, is the usual feature in such cases (Table 9.3).
 
Candidiasis
This common condition is due to an opportunistic yeast candida albicans. It presents in males as balanoposthitis with fissuring of the prepuce.
Fig. 9.9: Groove sign
70
Fig. 9.10: Elephantiasis of labia majora and clitoris as a sequel to LGV
A moist, sodden whitish plaque is seen, on removal of which an erythematous, erosive area is revealed. There may be isolated, peripheral vesiculopustules.
Demonstration of the fungus is simple. A surface-scraping of the lesions mounted in 10 percent potassium hydroxide solution, shows up budding pseudohyphae in abundance. There is frequently concomitant diabetes mellitus.
 
Traumatic Ulcers
These are seen in males in the form of sharply demarcated, usually linear cuts on the genitalia. There is a history that the condition developed or is noticed immediately after sexual intercourse. There is a tendency to spontaneous healing if further intercourse is avoided. However, these traumatic ulcers may show superimposition of a sexually transmitted condition whereupon the lesion changes its morphological characteristics. 71
Table 9.3   Differential diagnosis-donovanosis is lymphogranuloma venereum
Donovanosis (granuloma inguinale)
Lymphogranuloma venereum (LGV)
1. Causative agent
Calymmatobacterium granulomatis
Chlamydia trachomatis subtypes L1, L2, L3
2. Incubation period:
3-90 days
6–42 days
3. Morphology:
Fleshy, exuberant, beefy-red, nonindurated, nontender, single elevated granulomatous ulcer, which bleeds profusely on touch
Transient, herpetiform, vesicular lesion, which heal spontaneously
4. Inguinal lymph adenitis
Conspicuously absent
It is its hall mark the inguinal syndrome with a tendency to suppurate and form multiple fistulae in males and anorectal ulceration and hyperplasia in females
5. Sites of affliction:
Its organism affects the moist stratified squamous epithelium of the cavity and the genitals
Its organism affects primarily the lymphatics of the groins, genital and rectum
6. Constitutional symptoms Absent
Hyperglobulinemia its reversal of malaise, arthralgia and are present either before or along with its local manifestation
7. Elephantiasis:
Uncommon, if present, secondary to healing ulcers
Common, ulcers are its secondary feature
8. Strictures:
Uncomman, if present, secondary to anus
Comman and affect rectum
9. Tissue smears:
Presence of Donovan bodies in mononuclear cells in Giemsa stained tissue smear and section is diagnostic
Unhelpful72
10. Blood investigations Inconclusive
Marked, characterized by fever, albumin: Globulin ratio, raised erythrocyte sedimentation rate and leucocytosis are complimentary
11. Serological test:
Unrewarding
The demonstration of a four- fold or a greater rise in titre microimmunofluorescent antibody with immunofluorescent type specificity for type 1,2,3 strains of Chlamydia trachomatis confirms the diagnosis
 
Non-sexually Transmitted Disease
 
Squamous Cell Carcinoma
A squamous cell carcinoma of the penis may frequently pose a diagnostic problem. The resemblance to donovanosis can be close, with both conditions exhibiting a granulomatous, ulcerated growth with hypertrophic edges (Fig. 9.11). In later stages, of course, involvement of the inguinal lymph nodes occurs in carcinoma. These are firm to hard and subsequently become fixed to deeper structures. However, in the earlier stages, both a tissue smear and a biopsy are prerequisites. Histopathologically, although epidermal changes can be similar, the presence of numerous mitoses, irregularity and bizarre pattern of nuclei and the presence of horn pearls, in carcinoma, help in differentiating the two conditions.
Another problem arises when the two diseases are present together or when carcinoma follows as a sequel to an earlier lesion of donovanosis. Both these situations can arise.4 In such cases it might be wiser to institute full therapy for donovanosis and note the response. Inadequate response to treatment would necessitate surgical treatment of carcinoma. 73
Fig. 9.11: Squamous cell carcinoma
 
Cutaneous Tuberculosis
Scrofuloderma may present in the inguinal region as discharging sinuses and ulcers (Fig. 9.12). However, usually the underlying nodes can be felt as a matted mass, to which the sinuses are fixed. Tuberculous ulcers are necrotic, friable, have undermined edges, and have a bluish margin. Tuberculosis verrucosa cutis may, very rarely, present on the genito-inguinal region. In such cases, confusion with the hypertrophic variant of donovanosis may arise. Histopathology provides the answer; the former will show areas of caseation necrosis with a surrounding granuloma of epithelioid cells and lymphocytes. An admixture of polymorphonuclear cells may be present special staining with Ziehl-Neelsen stain will reveal acid fast bacilli.5,6
 
Filariasis
The late stage of filaria presents as elephantiasis of the genitalia However, the absence of genital ulcerations in the past, an 74initial acute episode of fever with (usually) scrotal swelling, and microfilaria seen on a peripheral blood smear taken at night, all distinguish it from donovanosis.
Fig. 9.12: Scrofuloderma involving the inguinal glands
Fig. 9.13: Genital fixed drug eruption
75
 
Fixed Drug Eruptions
This can be diagnosed by its morphological features namely single well-defined superficial erosive lesions with no regional lymphadenopathy. The lesion is preceded or accompanied by itching and/or burning. Patients often do not relate their complaints to the use of drugs or their nature. This is especially important in developing countries. A drug history should, therefore, be pursued thoroughly and systematically. In cases, where the nature of the drug is not known to the patient, eliciting the complaint for which the drug was taken may be helpful. Provocating the lesion(s) with the suspecting drug confirms the diagnosis and may help in preventing recurrences in future. It also allays the patients’ anxiety regarding the venereal origin of the disease (Fig. 9.13).7
 
References
  1. Sehgal VN, Prasad AL. Chancroid or chancroidal ulcers. Dermatologica. 1985;170:136–141.
  1. Borchardt KA, Hoke AW. Simplified laboratory technique for diagnosis of chancroid. Arch Dermatol. 1970;102:188–192.
  1. Chapel T, Brown WJ, Jeffries C, et al. The microbiological flora of penile ulcerations. J Infect Dis. 1978;137:50–6.
  1. Rajam RV, Rangiah PN. Donovanosis. World Health Organisation Monograph Series No. 24, 1954.
  1. Sehgal VN, Wagh SA. Cutaneous tuberculosis. Current concepts. Int J Dermatol. 1990;29:237–252.
  1. Sehgal VN. Cutaneous tuberculosis. Dermatol Clin. 1994;12: 645–653.
  1. Sehgal VN, Srivastava G. Fixed drug eruption (FDE): changing scenario of incriminating drugs. Int J Dermatol. 2006;45:897–908.

Donovanosis/Granuloma Inguinale, HIV/AIDSchapter 10

Genito ulcerative disease (GUD) is well-recognized in the developing world as a cofactor for heterosexual HIV transmission. Men with GUD are an important high frequency HIV transmitter core group in the general population but few interventions have targeted such individuals so far. Donovanosis is an uncommon GUD with low infectivity characterized by large ulcers that bleed readily and has been identified as a risk factor for HIV in men in Durban, South Africa. Donovanosis is also endemic in Papua New Guinea, India, Brazil and amongst the aboriginal community in Australia. This curious geographical distribution is unique to any of the sexually transmitted diseases (STD) and might lend itself to control measures not tried previously. In the 1950–60s a global eradication program was successfully introduced against yaws but this strategy has not been implemented against any of the STD. Donovanosis is a symptomatic disease usually diagnosed on clinical grounds and could be targeted for eradication. Any program would need to be community-based and require cooperation with both hospital doctors, private general practitioners, nurses, primary health care workers, pharmacists and traditional healers. Donovanosis is usually treated by readily available antibiotics but treatment failure may occur in advanced HIV disease. Drug compliance is often a problem but may be improved by counseling.1
Early implementation of an eradication program targeting men with donovanosis could have a significant impact in limiting the spread of HIV in donovanosis-endemic countries and would preempt the possibility of both the emergence of drug resistance and treatment failure in individuals with immune impairment. Consequent upon these revelations granuloma inguinale and HIV was accorded a unique status amongst genito ulcerative disease (GUD) and a search for their treatment came into be.277
Aforementioned consolidated information seem to have been emanated from the work done earlier in Durban, where, in a study of 2,682 selected attenders at a sexually transmitted diseases (STD) clinic for blacks in Durban, antibodies to human immunodeficiency virus type 1(HIV-1) were detected in 63 (2.4%)--30 of 937 women (3.2%) and 33 of 1,745 men (1.9%). Women aged 15–19 years (P = 0.002) were at greater risk of HIV-1 infection than women of other age groups. Whereas amongst men, HIV-1 seropositivity was associated with genito ulcerative disease (GUD) (P = 0.007) and donovanosis (granuloma inguinale) (P = 0.02). Amongst seropositive men with donovanosis the probability of HIV-1 infection increased as the duration of lesions increased. When HIV-1 seropositive women were compared with a subgroup of 73 seronegative women with GUD, inflammatory cytological changes were associated with antibodies to HIV-1 (P = 0.02). Among women overall, HIV-1 seropositivity was associated with previous syphilis (P = 0.03). In men herpes zoster (P = 0.04) and in women lymphadenopathy (P = 0.002) accounted for HIV-1 seropositivity in patients with medical complaints. HIV-1 seropositivity in men with gonorrhea and genital warts was less than in men without gonorrhea (P = 0.001) and genital warts (P = 0.03). These results support the causal hypothesis of HIV transmission whereby mucosal discontinuity acts as a portal of entry for the virus. GUD and cervical inflammation secondary to STDs in seronegative subjects may facilitate HIV transmission. The relative risks of various STDs are probably dependent upon the duration of epithelial damage and exposure to HIV-1.3 An association of HIV, genital ulceration, and granuloma inguinale was aptly focused attention to in the past, which set in motion, the acquisition of the subsequent all important work on the subject.46
Ever since the work in this direction is continuing and a few intriguing observations have been made to enrich the knowledge available thus far. Malignant transformation of donovanosis (granuloma inguinale) in a HIV-positive patient is extraordinary and should be taken cognizance of because of the chronic natural history of the disease. Histopathology is an essential supplement for the diagnosis.7 Donovanosis with 78autoamputation of penis in a HIV-2 infected person was another valuable contribution.8 Furthermore, it is useful to review the recent articles, from different endemic area of the world.9,10
 
References
  1. O'Farrell N. Global eradication of donovanosis: an opportunity for limiting the spread of HIV-1 infection. Genitourin Med. 1995;71:27–31.
  1. Manders SM, Baxter JD. Granuloma inguinale and HIV: a unique presentation and novel treatment regimen. J Am Acad Dermatol. 1997;37:494–496.
  1. O'Farrell N, Windsor I, Becker P. HIV-1 infection among heterosexual attenders at a sexually transmitted diseases clinic in Durban. S Afr Med J. 1991;80:17–20.
  1. O'Farrell N, Coetzee K. HIV and granuloma inguinale in Durban. S Afr Med J. 1990;78:220.
  1. O'Farrell N. HIV, genital ulceration, and granuloma inguinale. Br Med J (Clin Res Ed). 1988;296:935.
  1. O'Farrell N. AIDS, sex, and genital ulceration. Lancet. 1988;1:355.
  1. Sardana K, Garg VK, Arora P, Khurana N. Malignant transformation of donovanosis (granuloma inguinale) in a HIV-positive patient. Dermatol Online J. 2008;14:8.
  1. Chandra Gupta TS, Rayudu T, Murthy SV. Donovanosis with auto-amputation of penis in a HIV-2 infected person. Indian J Dermatol Venereol Leprol. 2008;74:490–492.
  1. Wu JJ, Huang DB, Pang KR, Tyring SK. Selected sexually transmitted diseases and their relationship to HIV. Clin Dermatol. 2004;22:499–508.
  1. Kramer PB. Knowledge about AIDS and follow-up compliance in patients attending a sexually transmitted disease clinic in the highlands of Papua New Guinea. P N G Med J. 1995;38:178–190.

Treatment Optionschapter 11

Donovanosis has, for long, presented difficulties in treatment. Until the early part of this century, surgery was employed to excise the lesion along with the margin of normal tissue. Besides the technical problems, the resulting scar often broke down to cause a recurrence. Aragao and Vianna1 were the pioneers in the use of potassium antimony tartrate. They used a 1–2 percent solution in normal saline or 5 percent dextrose intravenously, repeated on alternate days. Although successful in the early stages, chronic cases were very resistant to this form of therapy. Fouadin, a trivalent antimony preparation, was also used2 as were other antimonials. The toxicity and antimony fastness-recurrent lesions developing resistance—were the main drawbacks of antimonial therapy.
 
Streptomycin (Isos, Cipstryn)
Barton et al3 used this drug in the treatment of donovanosis initially. Greenblatt et al4 organized the first large scale trial of streptomycin and attempted to rationalize the dosage schedule. A dosage of 4 g per day in divided doses for 5 days, was found to be optimal. Donovan bodies disappeared from lesions on an average of 6 days after initiation of therapy, while healing occurred 1–2 weeks after its cessation. There were few relapses. Other workers57 confirmed the efficacy of streptomycin but used different dosage schedules. Kupperman et al8 in another well-documented study found that streptomycin administered in total dosage of more than 20 g resulted in therapeutic cure in all cases, while recurrences were experienced with smaller dosage Rajam and Rangiah,9 however, had commendable results in smaller (10–20 g) daily doses over a period of 10 days. Lal et al10 too reported similar findings.
Failure of this drug was later reported by some workers from India11,12 and abroad.13 The higher risk of side effects14 has further discouraged its use.80
It is a water soluble aminoglycoside derived from Streptomyces griseus. It is marketed as the sulfate salt of streptomycin. The chemical name of streptomycin sulfate is D-Streptamine. It is used to reduce the development of drug-resistant bacteria and maintain the effectiveness of streptomycin and other antibacterial drugs, streptomycin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. It is indicated for use in mycobacterium avium complex infections including cutaneous and systemic tuberculosis. Accordingly, it is currently used only as an alterntive to antitubercular therapy where drug resistant is apparent. It is administred doses of 15 mg/kg daily maximum 500 mg to 1 gram daily or intermittent intramuscularly (IM).
 
Tetracycline (Hostacycline, Subamycin)
Terramycin (oxytetracycline) and Aureomycin l chlortetracycline) were tested in the treatment of donovanosis. Terramycin was found to be effective in its treatment in optimal dosage of 2 g per day over a period of 10–14 days, by the oral route.1517
Similarly, aureomycin was found to be equally effective.8,1821 The optimal dosage was the same as that of terramycin given above.
Low cost, high efficacy and ease of administration make tetracyclines the drug of first choice in donovanosis.14
They are so named for their four (“tetra-”) hydrocarbon rings (“-cycl-”) derivation (“-ine”). More specifically, they are defined as “a subclass of polyketides having an octahydrotetracene-2-carboxamide skeleton”. They are collectively known as “derivatives of polycyclic naphthacene carboxamide”.
They are a group of broad-spectrum antibiotics whose general usefulness has been reduced with the onset of bacterial resistance. Despite this, they remain the treatment of choice for some specific indications including Calymmatobacterium granulomatis, a causative organism. It is available either as tablates and capsules. Its doses 250 to 500 mg every 6 hours, may be increase to 4 grams a day in severe cases for a period of 7 to 14 days. 81
 
Co-trimoxazole (Trimethoprim, Triprim, Bactrim)
Although sulfonamides are ineffective in the treatment of donovanosis, a combination of sulfamethoxazole and trimethoprim (co-trimoxazole) was found to be useful in treatment of this disease.22 In a subsequent follow-up only 2 out of 116 patients showed a recurrence after administration of two tablets twice a day for 10–15 days. As confirmed by Rosen et al23 co-trimoxazole has become viable alternative to tetracycline. Treatment schedule is given in the Table 11.1.
It is a bacteriostatic antibiotic mainly used in the prophylaxis and treatment of urinary tract infections. It belongs to the class of chemotherapeutic agents known as dihydrofolate reductase inhibitors. It is a combination of sulfamethoxazole 400 mg and trimethoprim 80 mg. It is available as tablets. The usual dose is 960 mg to 2.88 grams daily given in two divided doses in mild to severe cases for a period of 14 to 21 days.24
 
Chloramphenicol (Aglomycetin, Chlorocin)
This drug is also highly effective in the treatment of donovanosis, both orally and parenterally.8,19,2527
Table 11.1   Treatment schedule
Drugs
Daily dose
Total dose
Duration
1. Tetracycline (oral)
  1. Terramycin
  2. Aureomycin
2 g in four equally divided doses
20–40 g
10 to 20 days
2. Streptomycin (intramuscular)
2 g in two equally divided doses
20–40 g
10 to 20 days
3. Co-trimoxazole (oral) Trimethoprim 80 mg + Sulfamethoxazole 400 mg
2 tablets 2 times a day
20–30 tablets
10 to 15 days
The treatment may be prolonged in case the recovery is partial/incomplete.
82
As with tetracyclines, the optimal oral dosage is 2 g per day in divided doses for 10–14 days. However, the serious, although rare, side effect of bone marrow depression caused by this drug requires that it should only be used sparingly.
 
Other Drugs
Ampicillin, in the dosage of 1 to 2 g daily for 14 days, was effective in two studies28,29 but ineffective in another.30 Triacetyloleandomycin was extremely efficacious in a single study.31 Erythromycin, both parenterally and orally, are useful in the treatment of donovanosis.32, 33 Gentamicin in the dosage of 1 mg/kg body weight thrice a day was found effective in all 9 cases treated with this drug.13 Penicillin34 has been found to be ineffective against donovanosis.
 
Azithromycin (Azifast, Azid)
This is a semisynthetic macrolide antibiotic chemically related to erythromycin and clarithromycin. It is effective against a wide variety of bacteria, including Calymmatobacterium granulomatis causing donovanosis/granuloma inguinale. It is an unusual antibiotic in that it stays in the body for quite a while (has a long half-life), allowing for once a day dosing and for shorter treatment courses for most infections. It is FDA approved antibiotic. It should be administered empty stomach. Its possible side effects like stomach upset, vomiting and diarrhea should be focused attention at the time of prescribing the drug. This is the most frequently used antibiotic ever since its advent. Its dose variant from 500 to 2000 mg/day till the complete recovery of the lesions of GI is achieved. These aspects have been a subject of several reports.3539
 
Ciprofloxacin (Biocip, Ciplox)
Ciprofloxacin hydrochloride, USP, a fluoroquinolone, is the monohydrochloride monohydrate salt of 1-cyclopropyl-6-fluoro-1, 4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid. It is a synthetic broad-spectrum 83antimicrobial agent for oral administration. It is a faintly yellowish to light yellow crystalline substance with a molecular weight of 385.8. It is available as tablets /suspention for oral use. It has successfully been used in treatment in GI in a single patient.40 It is also available for intravenous (IV) infusion. Norfloxacin has also been advocated for use in the treatment of donovanosis.41
 
Ceftriaxone (Cefocef, Comtrix)
Ceftriaxone (Cefotaxime): It is a sterile, semisynthetic, broad-spectrum cephalosporin antibiotic for intravenous (IV) / intramuscular administration. Ceftriaxone sodium is (6R,7R)-7-[2-(2-Amino-4-thiazolyl)glyoxylamido]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-as triazin-3-yl)thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 72-(Z)-(O-methyloxime), disodium salt, sesquihydrate. It is a white to yellowish-orange crystalline powder, which is readily soluble in water, sparingly soluble in methanol and very slightly soluble in ethanol. The pH of a 1 percent aqueous solution is approximately 6.7. The color of Rocephin solutions ranges from light yellow to amber, depending on the length of storage, concentration and diluent used. It contains approximately 83 mg (3.6 mEq) of sodium per gram of ceftriaxone activity.
Ceftriaxone and tazobactam (Montaz, Tazox): The preparation containing ceftriaxone and tazobactam are also available. The tazobactam is a pencillinate sulfone, structurally related to sulbactam. Being a beta-lactamase inhibitor, it is synergistic with many beta-lactamase labile drugs such as penicillins and cephalosporins. Tazobactam inhibits all beta-lactmases inhibited by clavulanic acid, but in addition it also has some activity against chromosomally mediated/induced (or derepressed) enzymes of Morganella morganii, Citrobacter freundii, Enterobacter cloacae, Serratia marcescens and Pseudomonas aeruginosa. Tazobactam also appears to be weaker enzyme inducer than other beta- lacamase inhibitors.84
The combination of tazobactam and ceftriaxone is active against all the organisms sensitive to ceftriaxone. In addition, it demonstrates synergistic activity (reduction in MICs for the combination versus those of each component) in a varity of organisms.
The usual adult dose is 1000/125–2000/250 mg of certriaxone/tazobactam given once a day (or in equally divided doses twice a day) depending upon the severity of the infection. The total daily dose should not exceed 4 gms (in terms of Ceftriaxone).
The Ceftriaxone per se was successfully used in a single daily IM injection of 1g diluted in 2 ml of 1 percent lignocaine in a study, while in another failure of single dose ceftriaxone in donovanosis (granuloma inguinale) was recorded.42,43 Nevertheless ceftriaxone is a vital drug and should be given adequate credence for the future use either alone or in combination with tazobactam. It is recommended that drugs should be administered tilee there is a complete regression of lesions.
 
Spectinomycin (Trobicin, Myspec)
Sterile powder contains spectinomycin hydrochloride which is an aminocyclitol antibiotic produced by a species of soil microorganism designated as Streptomyces spectabilis. Sterile spectinomycin hydrochloride is the pentahydrated dihydrochloride salt of spectinomycin. Spectinomycin hydrochloride is isolated as a white to pale buff crystalline dihydrochloride pentahydrate powder, molecular weight 495, and is stable in the dry state for 36 months.
It is available for injectable suspension (USP). Its sterile powder should be used only to treat/prevent infections that are proven/strongly suspected to be caused by bacteria. It helps to reduce the development of drug-resistant bacteria and maintain the effectiveness. Recommended dose of more than 100 mg/kg daily with a caution that it may cuase sudden gasping, low blood pressure, or a very slow heartbeat.
It was mooted for the treatment of donovanosis (granuloma inguinale), however, it was a single dose treatment of failure and 85did not yield anticipated outcome. The drugs shold sparingly be used.44
 
Trovafloxacin (Trovan)
It is a broad-spectrum antibiotic that inhibits DNA supercoiling in various bacteria by blocking the activity of DNA gyrase and topoisomerase IV. It belongs to the class of drugs called fluoroquinolones. This medication is used to treat serious infections including life-or-limb-threatening infections, pneumonia, complicated abdominal infections, gynecologic and pelvic infections, and skin infections. Its recommended dose is 200 mg/day, either by oral or intravenus for a period 10 to 14 days in adults of diabetic foot infection or skin and skin structure infections. Accordingly, trovafloxacin was used for the treatment of chronic granuloma inguinale with acceptable results.45 This a new addition to the existining drugs, and should be made use of feature. Precurability may ba a problem at present.
 
Thiamphenicol/Thiamphenicol Dextrose Sphenoidal
It is is a broad-spectrum antibiotic, active against both gram-positive and gram-negative bacteria and especially effective against anaerobes. It is the methyl - sulfonyl analog of chloramphenicol and has a similar spectrum of activity, but is 2.5 to 5 times as potent. Like chloramphenicol, it is insoluble in water, but highly soluble in lipids. It is used in many countries as a veterinary antibiotic, but is available in China and Italy for use in humans. Thiamphenicol is also widely used in Brazil, particularly for the treatment of sexually transmitted infections (STIs) and pelvic inflammatory disease (PID).46 Its main advantage over chloramphenicol is that it has never been associated with aplastic anemia.
There appears to be no firm recommendation of dosages. However, after a 500 mg oral dose of each of thiamphenicol and chloramphenicol, the plasma levels appear to be similar. A high level of active thiamphenicol and a low level of chloramphenicol were found in the urine after 24 hours. The half-life of thiamphenicol is significantly increased in renal insufficiency, but is almost unaffected by liver cirrhosis.86
Thiamphenicol was used in the treatment of 10 patients with donovanosis for two weeks. In 8 of them, included 2 HIV infected patients, lesions healed. The safety profile of thiamphenicol makes it a useful and cost-effective agent in the management of donovanosis. Randomized controlled trials should be conducted with these treatment options.47
The briefs of several drugs dried for alleviating the symptoms any signs of GI are mentioned. Ultimately, World Health Organization (WHO) and center for Disease Control and Prevention (CDC) meticulously took stock of short and long- term efficacy of these drugs in potentially chronic, progressive, and destructive disease and came to certain conclusions. Now, they are stipulated recommendation for use in the treatment of the disease for the future. There is nothing much to use between the too never-the-less, it is pertinent to project them in the tables for instant reference (Tables 11.2 and 11.3).
Table 11.2   Stipulated CDC recommendation for treatment of donovanosis (GI)
Recommended regimen
Azithromycin 1 gm on the first day, and then 500 mg every day
Or
Doxycycline 100 mg orally twice a day
Alternative regimens
Erythromycin 500 mg, orally 4 times a day
Or
Tetracycline 500 mg, orally 4 times a day
Or
Trimethoprim 80 mg with sulfamethoxazole- 400 mg, orally 2 tablets twice daily for a minimum of 14 days
Note: The addition of a parenteral aminoglycoside such as gentamicin should be considered in HIV positive patients.
Appropriate surgical intervention may be needed in pseudo-elephantiasis and other complications.
87
Table 11.3   Stipulated WHO recommendation for treatment of donovanosis (GI)
Granuloma Inguinale
Recommended regimen
Doxycycline 100 mg orally, twice a day for 3 weeks and until all lesions have completely healed
Alternative regimen
Azithromycin 1 gm, orally once a week for at least 3 weeks or until all lesions have completely healed
Or
Ciprofloxacin 750 mg twice a day, orally at least for 3 weeks or until all lesions have completely healed
Or
Erythromycin 500 mg orally, 4 times a day, at least for 3 weeks or until all lesions have completely healed
Or
Trimethoprim-sulfamethoxazole, one double strength (160–800 mg) tablet orally twice a day for at least 3 weeks or until all lesions have healed completely
Some specialists recommend addition of aminoglycoside (gentamicin 1 mg/kg, every 8 hourly) to these regimens if improvement is not evident with these regimens within first few days of therapy
 
References
  1. Aragao H, Vianna G. Unter Suchungen Ueber das granuloma venereum. Mein Inst Oswaldo Cruz. 1913;5:211–238.
  1. Rajam RV. A note on the treatment of infective granuloma with Fouadin. Ind Med Gaz. 1934;69:372–375.
  1. Barton RL, Craig RM, Schwemlein GX, Bauer TJ. Granuloma inguinale treated with Streptomycin-Report of 3 cases. Arch Dermatol Syphilol. 1947;56:1–6.
  1. Greenblatt RB, Dienst RB, Cupperman HS, Reinstein BS. Granuloma inguinale-Streptomycin therapy and research. J Vener Dis Inform. 1942;48:183–188.
  1. Jacoby A, Rosenthal T, Sobel N. Ambulatory treatment of granuloma inguinale with streptomycin. Am J Syph Gonorrhea Vener Dis. 1949;33:76–79.
  1. Marshal LC, Rodriguez J. Granuloma inguinale—Treatment with streptomycin. J Am Med Assoc. 1948;137:1293–1295.
  1. Stewart JJ, Laur WE: Streptomycin therapy of granuloma inguinale. Am J Syph Gonorrhea Vener Dis. 1949;33:65–67.
  1. Kupperman HS, Greenblatt RB, Dienst RB. Streptomycin in the therapy of granuloma inguinale. J Am Med Assoc. 1948;136:84–89.
  1. Rajam RV, Rangiah PN. Donovanosis. World Health Organisation Monograph Series No. 24, 1954.
  1. Lal S. Continued efficacy of streptomycin in the treatment of granuloma inguinale. Br J Vener Dis. 1971;47:454–455.
  1. Rama Rao NSV, Patnaik R. Donovanosis at Kakinada (A clinical study). Ind J Derm Venereol Lepr. 1966;32:100–105.
  1. Serma JS. Granuloma vanereum—A problem in Guntur. Ind J Derm Venereol Lepr. 1957;23:9–15.
  1. Maddocks I, Anders EM, Dennis E. Donovanosis in Papua New Guinea. Br J Vener Dis. 1976;52:190–196.
  1. World Health Organisation: Nongonococcal urethritis and other sexually transmitted diseases of public health importance. WHO Technical Report Series No. 660: 1981.pp.52.
  1. Greenblatt RB, Barfield WE, Dienst RB, West RM. Terramycin in the treatment of granuloma inguinale. J Vener Dis Inf. 1951;32:113–115.
  1. Greenblatt RB, Barfield WE, Dienst RB, West RM, Zises M. A five-year study of antibiotics in the treatment of granuloma inguinale. Am J Syph Gonorrhea Vener Dis. 1952;36:186–191.
  1. Wright LT, Prigot A, Dilorenzo JC, Whitaker JC, Marmell M. Oral terramycin in rapid treatment of gonorrhoea and other venereal diseases. Am J Syph Gonorrhea Vener Dis. 1951;35:490–495.
  1. Greenblatt RB, Wammock VS, West RM, Dienst RB, Chen CH. Oral aureomycin in the therapy of granuloma inguinale. Am J Syph Gonorrhea Vener Dis. 1949;33:593–598.
  1. Robinson RC, Cronk B: Granuloma inguinale-further observations on results of treatment with aureomycin and chloramphenicol. Am J Syph Gonorrhea Vener Dis. 1951;35:378–382.
  1. Robinson RC, Elmendorf DF Jr, Zheutlin HE: Aureomycin in the treatment of granuloma inguinale. Am J Syph Gonorrhea Vener Dis. 1949;33:389–396.
  1. Wammock VS, Greenblatt RB, Dienst RB, Chen C, West RM. Aureomycin in the treatment of granuloma inguinale and lymphogranuloma venereum. J Invest Derm. 1950;14:427–434.
  1. Garg BR, Lal S, Sivamani S: Efficacy of Co-trimoxazole in donovanosis—A preliminary report. Br J Vener Dis. 1978;54:348–349.
  1. Rosen T, Tschen JA, Ramsdell W, Moor J, Markham B. Granuloma inguinale. J Am Acad Dermatol. 1984;11:433–437.
  1. Birthistle K, Greig J, Hay P. Failure of trimethoprifm in the treatment of donovanosis. Genitourin Med. 1997;73:224–225.
  1. Greenblatt RB, Wammock VS, Dienst RB, West RM. The newer antibiotics in the therapy of the venereal diseases other than syphilis. J Vener Dis Inf. 1950;31:45–50.
  1. Robinson RC, Wells TL. Intramuscular chloramphenicol in the treatment of gonorrhoea, and granuloma inguinale. Am J Syph Gonorrhea Vener Dis. 1952;36:264–268.
  1. Zises M, Smith GC. Nine cases of granuloma inguinale treated with chtoromycetin. Am J Syph Gonorrhea Vener Dis. 1951;35: 294–296.
  1. Breschi LC, Goldman G, Shapiro SR. J Am Vener Dis Assoc. 1975; 1:188.
  1. Thew MA, Swift JT, Heaton CL. Ampicillin in the treatment of granuloma inguinale. JAMA. 1969;210:866–867.
  1. Davis CM: Granuloma inguinale—A clinical, histological and ultrastructural study. JAMA. 1970;211:632–636.
  1. Kardel-Vegas F, Covit J, Soto JM. Treatment of granuloma inguinale with triacetyloleandomycin. Arch Dermatol. 1961;84: 248–255.
  1. Ghosh S, Ghosh R. Donovanosis treated with erythromycin parenterally. Report of a first case. Br J Vener Dis. 1959;35:260–261.
  1. Robinson H,’ Cohen ‘MM.’ Treatment of granuloma inguinale erythromycin. J Invest Derm. 1953;20:407–409.
  1. Nelson RA. Penicillin in the treatment of granuloma inguinale. Am J Syph. 1949;28:611–614.
  1. Mein J, Bastian I, Guthridge S, Farmer B, Bowden F. Donovanosis: sequelae of severe disease and successful azithromycin treatment. Int J STD AIDS. 1996;7:448–451.
  1. Bowden FJ, Mein J, Plunkett C, Bastian I. Pilot study of azithromycin in the treatment of genital donovanosis. Genitourin Med. 1996;72:17–19.
  1. Arevalo Morles C, Hernandez I, Ferreiro MC. Donovanosis: treatment with azithromycin. Int J STD AIDS. 1997;8:54–56.
  1. Bowden FJ, Savage J. Donovanosis: treatment with azithromycin. Int J STD AIDS. 1998;9:61–62.
  1. Bowden FJ, Savage J. Azithromycin for the treatment of donovanosis. Sex Transm Infect. 1998;74:78–79.
  1. Ahmed BA, Tang A. Successful treatment of donovanosis with ciprofloxacin. Genitourin Med. 1996;72:73–74.
  1. Ramanan C, Sarma PS, Ghorpade A, Das M. Treatment of donovanosis with norfloxacin. Int J Dermatol. 1990;29:298–299.
  1. Evans DT. Failure of single dose ceftriaxone in donovanosis (granuloma inguinale). Genitourin Med. 1992; 68: 146.
  1. Merianos A, Gilles M, Chuah J. Ceftriaxone in the treatment of chronic donovanosis in central Australia. Genitourin Med. 1994; 70:84–89.
  1. O'Farrell N. Failure of single dose spectinomycin in granuloma inguinale (donovanosis). Trans R Soc Trop Med Hyg. 1990;84: 862.
  1. Hsu SL, Chia JK. Trovofloxacin for the treatment of chronic granuloma inguinale. Sex Transm Infect. 2001;77:137.
  1. Fuchs FD “Tetraciclinas e cloranfenicol”. Farmacologia clínica: fundamentos da terapêutica racional. In Portuguese (Fuchs FD, Wannmacher L, Ferreira MB eds.) 3rd edn. Rio de Janeiro: Guanabara Koogan. 2004.pp.375. ISBN 0-7216-5944-6.
  1. Belda W Jr, Velho PE, Arnone M, Romitti R. Donovanosis treated with thiamphenicol. Braz J Infect Dis. 2007;11:388–389

Conclusionchapter 12

Donovanosis is primarily a disease occurring in the tropics. Inspite of this, emphasis has usually been laid on its occurrence in some parts of India, viz South and South-East, thus making the problem less concentrated in other parts. It is, therefore, imperative to ‘suspect and consider donovanosis’ as an important etiologic cause of genital ulcers which has been well demonstrated1 where its frequency amongst the STD was found to be 3.99 percent in the capital city. Its frequency has been reported to vary from 0.3 percent2 to 6.3 percent3 in the Indian subcontinent, though higher percentages have been reported elsewhere.
Donovanosis occurred mostly in the sexually vulnerable age group teenagers seemed to be affected frequently in comparison to other studies. Higher incidence in younger individuals is attributed to early physical maturity and exposure to sex-stimulating literature in magazines, radio and television, as well as the apathetic attitudes of parents towards the small boys which forced them to leave their homes, thus falling into bad company, leading to homosexual and heterosexual exposure.4
The high male/female ratio observed may be misreading as many females; mainly prostitutes, who constituted the reservoir of infection, hardly reported for check-up. Low socioeconomic status and education of the majority of the patients emphasized the fact that this group was at risk. Prostitutes are responsible for the infection and continued to propagate the disease as they do not have periodic check-ups or treatment. The variable incubation period, chronic course of the disease and predominant involvement of the genitalia is in accordance with the findings of previous workers.57 The ulcerative variant expressing as the fleshy, exuberant form is the commonest. The shorter the duration, it is more difficult to demonstrate Donovan bodies in tissue smears. Similarly, in certain chronic 92lesions where fibrosis and lack of granulation tissue is present, it is difficult to demonstrate Donovan bodies.
The limitations of the tissue smear are obvious in some varieties of donovanosis, it was difficult to demonstrate Donovan bodies in early donovanosis, in two chronic cases, or with the necrotic variant Rajam and Rangiah6 have expressed similar views. In addition, cases which clinically suggest malignancy necessitate biopsy.8 Histopathological sections are of great value in the diagnosis of each of the clinical varieties of donovanosis. In three cases WHO were clinically diagnosed as donovanosis, Donovan bodies were not found in repeated tissue smear examinations, but were clearly shown in histopathological sections. Pund and Greenblatt9 described five essential histopathological features for the diagnosis of donovanosis.10 Their main emphasis was on the massive cellular infiltrate formed predominantly by plasma cells, a paucity of lymphocytes, diffuse sprinkling of polymorphonuclears leucocytes with focal collections, pronounced epithelial proliferation at the margins, and the presence of large, mononuclear cells in the infiltrate, which is considered to be pathognomonic. Intracellular and extracellular Donovan bodies of varying morphology and vascular proliferation and dilatation are also prominent in the lower dermis. The vascular proliferation is especially marked in the ulcero-granulomatous variant of Donovanosis.
Donovan bodies are easily identifiable in slow Giemsa stained tissue sections, and are easier to locate than in tissue smears. The characteristic cellular infiltrate of plasma and mononuclear cells and the extensive ulceration with acanthosis and rete-ridge elongation at the margins are the other characteristics features. Pseudoepitheliomatous hyperplasia is observed in only a few tissue sections, none of which show features of malignancy. Beerman and Sonck11 emphasized the prominence of this feature.11 According to them, mitotic figures were not so numerous and ‘pearl’ formation not so prominent in epitheliomas compared with pseudoepitheliomatous hyperplasia neutrophilic microabscesses in the epidermis and localized collections of neutrophils in the upper dermis are 93other features. Such findings were reported earlier by Rajam and Rangiah6 and Nayer et al.8
 
References
  1. Sehgal VN, Prasad AL. A clinical profile of donovanosis in a non-endemic area. Dermatologica. 1984;168:273–278.
  1. Vimala Bai K, Sulibhavi DG, Shyam Sunder P. A study of donovanosis. Ind J Derm Venereol Lepr. 1969;35:45–52.
  1. Rama Rao NSV, Patnaik, R. Donovanosis at Kakinada. A clinical study. Indian J Derm Vener Lepr. 1966;32:100–105.
  1. Sehgal VN: Venereal Diseases 2nd edn. Jaypee Medical Publishers,  New Delhi 1987.
  1. Lal S, Nicholas C. Epidemiological and clinical features in 165 cases of granuloma inguinale. Br J Vener Dis. 1970;46:461–463.
  1. Rajam RV, Rangiah PN. Donovanosis. World Health Organisation Monograph Series No. 24, 1954.
  1. Anonymous US Public Health Service. Management of chancroid, granuloma inguinale, lymphogranuloma venereum in general practice. US Public Health Service Publication No. 255 (US Department of Health Education and Welfare, Communicable Disease Centre, Venereal Disease Branch, Atlanta, 1964).
  1. Nayar M, Chandra M, Saxena HM, Bhargava NC, Sehgal VN. Donovanosis—A Histopathological study. Indian J Pathol Microbiol. 1981;24:71–76.
  1. Pund ER, Greenblatt RB. Specific histology of granuloma inguinale. Arch Path. 1937;23:224–230.
  1. Bedi TR. Perianal granuloma inguinale in a child (non-venereal transmission). Ind J Derm Venereol Lept. 1980;116:45–46.
  1. Beerman H, Sonck CE. The epithelial changes in granuloma inguinale. Am J Syph Gonorrhea Vener Dis. 1952;36:501–510.

Future Challengeschapter 13

Undoubtedly, donovanosis/granuloma inguinale is one of the extraordinary genito ulcerative diseases (GUDs) with exclusive clinical expression, the diagnosis of which is largely made on the basis of the demonstration of intra- and/or extracytoplasmic Donovan bodies. The causative organism Calymmatobacterium granulomatis was initially grouped with enterobacteriaceae, because Donovan bodies isolated from the ulcers cross reacted antigenically with Klebsiella rhinoscleromatis, K. pneumonae, and Escherichia coli. The etiological significance of the Donovan bodies per se is largely uncertain since they fail to produce skin lesions following the inoculation. However, an inoculum obtained from the fresh lesions, on the other hand, may do so easily.
Currently, very little information is available on this disease. Hence future planning should incorporate the details study of epidemiology in different parts of the globe comprising its distribution by race, climate and socioeconomic status. This should preferably be complimented by detailed sero-epidemological studies, should a suitable antigen be identified for this purpose. Incidentally, the organism has been claimed to have been cultured, the antigen prepared from the same not only may help in confirming the diagnosis, but also add the understanding of the natural history of the disease (vide supra). This may help in forming the characteristics of the endemic population and establish the risk of infection amongst the sex partners. Suitable control measures then shall be easy to translate for control programs.
Laboratory research to recover the organism in vitro shall have to be meticulously augmented. This will help us in defining the characteristics of the organism and in understanding the natural history and the pathogenesis of the disease. Thus the interaction of epidemiology, the host and the organism may add to our understanding of the disease. Study of immune 95markers IgA namely lymphocytes T-Pan and its subsets- T4 (helper/inducer) and T8 (suppressor/cytotoxic) B lymphocytes, immunoglobulins IgG, IgA and IgM may form a future plank to unravel several mysteries of donovanosis/GI.1
 
Reference
  1. Sehgal VN, Jain MK, Sharma VK. Lymphocyte subpopul-ations in donovanosis assessed by monoclonal anti-bodies and immunoglobulins. Genitourin Med. 1987;63:274–276.

Color Atlaschapter 14

Donovanosis/granuloma inguinale is one of the outstanding genito ulcerative diseases (GUDs). Its recognition through precise clinical description is considered paramount in the current context, for ulcerative/ulcero-granulomatius lesions are deemed favorite for HIV transmission. Although, the monograph recounts its salient clinical overtone, illustrated by exquisite black and white photographs, now a material for archives, yet its documentation by colored visuals is imperative to include, fostering the interest in the entity. An endeavor to rejuvenate/rekindle awareness in the entity is attempted through beautiful colored photographs. The chronological organization, corresponding to the respective text, of the photographs has been done in order to facilitate the learning process, thus enhancing its value as an impeccable document serving has a ‘ready reckon’.
Fig. 14.1.1:
97
 
 
Ulcerative/Ulcerogranulomatous Variant
A single, well-defined, friable, beefy red, nontender, nonindurated ulcer depicting profuse granulation tissue, bleeding on touch, and showing no necrosis on the surface (Figs 14.1.1 to 14.1.8). However, atypical variants were encountered (Figs 14.1.9 and 14.1.17).
Fig. 14.1.2:
Fig. 14.1.3:
98
Fig. 14.1.4:
Fig. 14.1.5:
99
Fig. 14.1.6:
Fig. 14.1.7:
100
Fig. 14.1.8:
Fig. 14.1.9:
101
Fig. 14.1.10:
Fig. 14.1.11:
102
Fig. 14.1.12:
Fig. 14.1.13:
103
Fig. 14.1.14:
Fig. 14.1.15:
104
Fig. 14.1.16:
Fig. 14.1.17:
105
 
Hypertrophic Variant
An irregular, friable, raised growth bleeding on touch, or an ulcer with a well-defined raised edge, and an elevated granulomatous base (Figs 14.2.1 to 14.2.7).
Fig. 14.2.1:
Fig. 14.2.2:
106
Fig. 14.2.3:
Fig. 14.2.4:
107
Fig. 14.2.5:
Fig. 14.2.6:
108
Fig. 14.2.7:
 
Necrotic Variant
A large, foul smelling, tender, nonindurated, irregular ulcer (Fig. 14.3.1).
Fig. 14.3.1:
109
 
Sclerotic Variant
A single, deep, undermined, with non-bleeding edges (Fig. 14.4.1).
Fig. 14.4.1:
 
Pseudobubo
A fluctuant swelling following affection of subcutaneous tissue of the groins (Fig. 14.5.1).
Fig. 14.5.1:
110
 
Pseudoelephantiasis (Figs 14.6.1 to 14.6.6)
Fig. 14.6.1:
Fig. 14.6.2:
111
Fig. 14.6.3:
Fig. 14.6.4:
112
Fig. 14.6.5:
Fig. 14.6.6:
113
 
Tissue Smears
Giemsa's stained (GS) tissue smears, depict Donovan bodies identified as mature and/or immature organisms, which are largely present inside the cytoplasm of mononuclear cells, and also outside these cells (Figs 14.7.1 to 14.7.3).
Fig. 14.7.1: Encapsulated mature Donovan bodies in a tissue smear (Giemsa-stain 1000)
Fig. 14.7.2: Uncapsulated immature donovan bodies (Giemsa-stain 1000)
114
Fig. 14.7.3: Uncapsulated immature donovan bodies (Giemsa stain 1000)
 
Histopathology
Microscopic pathology is fairly specific and may supplement the clinical diagnosis, in addition to Giemsa stained tissue smears (Figs 14.8.1 to 14.8.17).
Fig. 14.8.1: Donovan bodies in a slow (overnight) Giemsa stained tissue section (1000)
115
Fig. 14.8.2: Pseudoepitheliomatous hyperplasia of epidermis
Fig. 14.8.3: Dermal infiltrate of mononuclear and chronic inflammatory cells
116
Fig. 14.8.4: Dermal vascular dilatation, and proliferation
Fig. 14.8.5:
117
Fig. 14.8.6:
Fig. 14.8.7:
118
Fig. 14.8.8:
Fig. 14.8.9:
119
Fig. 14.8.10:
Fig. 14.8.11:
120
Fig. 14.8.12:
Fig. 14.8.13:
121
Fig. 14.8.14: Donovan bodies in a slow overnight (Giemsa-stained 1000)
Fig. 14.8.15:
122
Fig. 14.8.16:
Fig. 14.8.17:
123Index
Page numbers followed by f refer to figure and t refer to table
A Acquired immunodeficiency syndrome , Aglomycetin Antibody tests Atypical ulcerative variant Aureomycin Azithromycin , B Burst pseudobubo C Calymmatobacterium granulomatis , , , , , , , , Candida albicans Ceftriaxone Chancroid , , with bubo Chancroidal ulcer , Chlamydia trachomatis , , Chronic genitoulcerative diseases Ciprofloxacin Citrobacter freundii Clitoris Closed-safety-pin appearance Collection of donovan bodies Coronal sulcus and groin Co-trimoxazole Cutaneous tuberculosis D Delafield's hematoxylin-eosin Dermal infiltrate of mononuclear and chronic inflammatory cells vascular dilatation Donovan bodies , , , , Donovania granulomatis Donovanosis , , , , , , Doxycycline Dwarf chancroid E Elephantiasis of labia majora and clitoris Encapsulated mature donovan bodies in tissue smear Enterobacter cloacae Enzyme-linked immunosorbent assays Escherichia coli Expression of ulcerative donovanosis Extracellular donovan bodies , F Filariasis Fixed drug eruptions Fungating labial ulcers G Genital fixed drug eruption lesions Genitoulcerative diseases , , , , , Giemsa's stain , Granuloma inguinale , , , Granulomatis Groove sign H Haemophillus ducreyi Hematuria Herpes genitalis progenitalis Hostacycline Human immunodeficiency virus , , , infection Hypertrophic lesion of donovanosis on penis variant , , , I Incidence of donovanosis Incubation period , , Inguinal glands lymphadenitis K Klebsiella granulomatis pneumoniae rhinoscleromatis L Labia majora , Labial swelling Late syphilis Lymphogranuloma venereum , , , M Michaelis-Gutmann bodies Mons pubis Morganella morganii Morphology of chancroid on coronal sulcus Multiple ulcers simulating chancroid N Necrotic variant , Non-sexually transmitted disease Non-tender ulcers P Pathognomonic cell of Greenblatt Polycyclic erosions on glans penis Polymerase chain reaction Primary chancre chancre on glans penis Prognostic tests Pseudobubo , Pseudoelephantiasis , of penis Pseudoepitheliomatous hyperplasia of epidermis Pseudomonas aeruginosa R Rectovaginal fistulae S Sclerotic variant , Serratia marcescens Sexually transmitted diseases , , infections , Spectinomycin Squamous cell carcinoma , Stipulated CDC recommendation for treatment of donovanosis WHO recommendation for treatment of donovanosis Streptomyces griseus spectabilis Streptomycin , Subamycin Sulfamethoxazole Syphilis Systemic donovanosis T Tazobactam Terramycin Tetracycline , Thiamphenicol Traumatic ulcers Treatment of sexually transmitted infections Treponema pallidum Trimethoprim Trovafloxacin Typical ulcerative variant of donovanosis U Ulcer granulomatous variant Ulcerative donovanosis variant of donovanosis – Uncapsulated immature donovan bodies , V Vaginal discharge , Virus isolation W Warthin-Starry stain Wright's stain